educratsweb.com >> PATANJALI PRODUCT FOR HEALTH CARE - EDUCRATSWEB.COM

Patanjali Product for Health Care

Posted By educratsweb.com ❄ Health 🗓 Sunday September 8 2019 👁 10

Tag : # PRODUCT, FOR, HEALTH, CARE, PATANJALI, CARE, PRODUCT, FOR, HEALTH, PATANJALI,

Patanjali Product for Health Care / स्वास्थ्य देखभाल Full List

Patanjali Badam Pak / बादाम पाक

Badam Pak / बादाम पाक - 250 gm MRP - 130 Rs

Patanjali Badam Pak / बादाम पाक

Badam Pak / बादाम पाक - 500 gm MRP - 240 Rs

Patanjali Chyawanprash / च्यवनप्राश

Chyawanprash / च्यवनप्राश - 1 kg MRP - 190 Rs

Patanjali Chyawanprash / च्यवनप्राश

Special Chyawanprash / स्पेशल च्यवनप्राश - 1 kg MRP - 250 Rs

Patanjali Chyawanprash / च्यवनप्राश

Special Chyawanprash / स्पेशल च्यवनप्राश - 500 gm MRP - 130 Rs

Patanjali Digestives / पाचक

Pachak Ajwain / पाचक अजवाइन - 100 gm MRP - 46 Rs

Patanjali Digestives / पाचक

Pachak Anardana Goli / पाचक अनारदाना गोली - 100 gm MRP - 35 Rs

Patanjali Digestives / पाचक

Pachak Chhuhara / पाचक छुआरा - 100 gm MRP - 45 Rs

Patanjali Digestives / पाचक

Pachak Hing Goli / पाचक हींग गोली - 100 gm MRP - 50 Rs

Patanjali Digestives / पाचक

Pachak Hing Peda / पाचक हींग पेड़ा - 100 gm MRP - 50 Rs

Patanjali Digestives / पाचक

Pachak Hing Peda / पाचक हींग पेड़ा - 200 gm MRP - 60 Rs

Patanjali Digestives / पाचक

Pachack Jal Jeera / पाचक जल जीरा - 200 gm MRP - 60 Rs

Patanjali Digestives / पाचक

Pachak Jeera Khatti Mithi Goli / पाचक जीरा खट्टी मीठी गोली - 100 gm MRP - 35 Rs

Patanjali Digestives / पाचक

Pachak Methi Nimbu / पाचक मेथी निम्बू - 100 gm MRP - 32 Rs

Patanjali Digestives / पाचक

Pachak Shodhit Harad / पाचक शोधित हरड़ - 100 gm MRP - 35 Rs

Patanjali Digestives / पाचक

Jamun Vinegar (L) / जामुन विनेगर - 570 gm MRP - 65 Rs

Patanjali Fruit Juice / फलों का रस

Gulab Sharbat (L) / गुलाब शरबत - 750 gm MRP - 100 Rs

Patanjali Fruit Juice / फलों का रस

Litchi Drink / लीची ड्रिंक - 65 ml MRP - 5 Rs

Patanjali Fruit Juice / फलों का रस

Orange Squash / ऑरेंज स्क्वाश - 750 ml MRP - 75 Rs

Patanjali Fruit Juice / फलों का रस

Patanjali Mango Drink / पतंजलि मैंगो ड्रिंक - 65 gm MRP - 5 Rs

Patanjali Ghee / घीं

Desi Ghee / देसी घीं - 500 gm MRP - 270 Rs

Patanjali Ghee / घीं

Desi Ghee / देसी घीं - 1 kg MRP - 510 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Amrit Rasayana / अमृत रसायन - 500 gm MRP - 240 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Amrit Rasayana / अमृत रसायन - 1 kg MRP - 350 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Ashvagandha Capsule / अश्वगंधा कैप्सूल - 5 gm MRP - 50 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Ashvashila (capsule) / अश्वशिला (कैप्सूल) - 5 gm MRP - 70 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Gulkand / गुलकंद - 400 gm MRP - 55 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Isabgol Bhusi / इसबगोल भूसी - 100 gm MRP - 90 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Kesar / केसर - 1 gm MRP - 285 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Musli Pak / मूसली पाक - 200 gm MRP - 350 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Shilajeet Capsule / शिलाजीत कैप्सूल - 5 gm MRP - 85 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Shilajeet Rasayan / शिलाजीत रसायन - 20 gm MRP - 35 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Shilajeet Rasayan / शिलाजीत रसायन - 40 gm MRP - 70 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Shilajeet Sat / शिलाजीत सत - 20 gm MRP - 100 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Patanjali Power Vita / पतंजलि पावर वीटा - 500 gm MRP - 205 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Patanjali Cow’s Whole Milk Powder / मिल्क पाउडर - 200 gm MRP - 65 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Badam Rogan / बादाम रोगन - 60 ml MRP - 110 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Balm / बाम - 25 gm MRP - 40 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Shatavar Churna / शतावर चूर्ण - 100 gm MRP - 90 Rs

Patanjali Health & Wellness / स्वास्थ्य और कल्याण

Youvan Churna / यौवन चूर्ण - 100 gm MRP - 200 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Aloe Vera Juice With Orange Flavour (L) / एलो वेरा जूस - 1 ltr MRP - 200 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Aloevera Juice With Fiber (L) / एलो वेरा जूस - 1 ltr MRP - 180 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Amla Aloevera Juice with Lichi Flavour / अमला एलो वेरा जूस - 70 gm MRP - 5 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Amla Juice (L) / अमला जूस - 500 ml MRP - 55 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Amla Juice (L) / अमला जूस - 1100 gm MRP - 100 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Arjun Amla Juice / अर्जुन अमला जूस - 500 ml MRP - 80 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Giloy Juice / गिलोय जूस - 500 gm MRP - 80 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Giloy Amla Juice / गिलोय अमला जूस - 500 ml MRP - 90 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Karela Amla Juice (L) / करेला अमला जूस - 570 gm MRP - 75 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Lauki Amla Juice (L) / लौकी अमला जूस - 1 kg MRP - 90 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Thandai Powder / ठंडाई पाउडर - 500 gm MRP - 190 Rs

Patanjali Health Drinks / स्वास्थ्य पेय

Tulsi Panchang Juice / तुलसी पंचांग जूस - 570 gm MRP - 90 Rs

Patanjali Honey / शहद

Pure Honey Multiflora / हनी मल्टीफ्लोरा - 250 gm MRP - 75 Rs

Patanjali Honey / शहद

Pure Honey / हनी - 250 gm MRP - 70 Rs

Patanjali Honey / शहद

Pure Honey / हनी - 500 gm MRP - 135 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Marie Biscuits / मैरी बिस्कुट - 120 gm MRP - 12 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Nutty Delite / नुटी डिलाइट - 100gm MRP - 15 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Patanjali Doodh Biscuits / पतंजलि दूध बिस्कुट - 50gm MRP - 5 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Patanjali Doodh Biscuits / पतंजलि दूध बिस्कुट - 100 gm MRP - 10 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Nariyal Biscuit / नारियल बिस्कुट - 100 gm MRP - 10 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Nariyal Biscuit / नारियल बिस्कुट - 300 gm MRP - 30 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Orange Delite Biscuits / ऑरेंज डिलाइट बिसकिट्स - 75 gm MRP - 10 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Elaichi Biscuit / इलाइची बिस्कुट - 75 gm MRP - 10 Rs

Patanjali Biscuits & Cookies / बिस्कुट और कुकीज़

Aarogya Biscuit / आरोग्य बिस्कुट - 100 gm MRP - 10 Rs

Patanjali Spices / मसाले

Bandhani Hing / बंधानी हींग - 10 gm MRP - 20 Rs

Patanjali Spices / मसाले

Bandhani Hing / बंधानी हींग - 25 gm MRP - 40 Rs

Patanjali Spices / मसाले

Black Pepper Powder / पिसी काली मिर्च - 100 gm MRP - 125 Rs

Patanjali Spices / मसाले

Black Pepper Whole / साबुत काली मिर्च - 100 gm MRP - 120 Rs

Patanjali Spices / मसाले

Chaat Masala / चाट मसाला - 100 gm MRP - 36 Rs

Patanjali Spices / मसाले

Choley Masala / छोले मसाला - 100 gm MRP - 45 Rs

Patanjali Spices / मसाले

Coriander Powder / पिसा धनिया - 100 gm MRP - 30 Rs

Patanjali Spices / मसाले

Cumin Whole / ज़ीरा दाना - 100 gm MRP - 40 Rs

Patanjali Spices / मसाले

Fenugreek Whole / मेथी दाना - 100 gm MRP - 20 Rs

Patanjali Spices / मसाले

Garam Masala / गरम मसाला - 100 gm MRP - 65 Rs

Patanjali Spices / मसाले

Red Chilli Powder / पिसी लाल मिर्च - 200 gm MRP - 60 Rs

Patanjali Spices / मसाले

Sabzi Masala / सब्ज़ी मसाला - 100 gm MRP - 38 Rs

Patanjali Spices / मसाले

Turmeric Powder / पिसी हल्दी - 100 gm MRP - 24 Rs

Patanjali Spices / मसाले

Turmeric Powder / पिसी हल्दी - 200 gm MRP - 43 Rs

Patanjali Spices / मसाले

Ajowan / अजवाइन - 100 gm MRP - 38 Rs

Patanjali Candy / कैंडी

Amla Candy / अमला कैंडी - 500 gm MRP - 140 Rs

Patanjali Candy / कैंडी

Amla Chatpata / अमला चटपटा - 500 gm MRP - 145 Rs

Patanjali Candy / कैंडी

Bel Candy / बेल कैंडी - 500 gm MRP - 140 Rs

Patanjali Candy / कैंडी

Mango Candy / आम कैंडी - 250 gm MRP - 55 Rs

Patanjali Herbal Tea / हर्बल चाय

Divya Peya / दिव्य पेय - 100 gm MRP - 50 Rs

Patanjali Herbal Tea / हर्बल चाय

Divya Herbal Peya / दिव्य पेय - 50 gm MRP - 70 Rs

Patanjali Jam / जैम

Mix Fruit Jam / मिक्स फ्रूट जैम - 500 gm MRP - 70 Rs

Patanjali Jam / जैम

Pineapple Jam / पाइनएप्पल जैम - 500 gm MRP - 70 Rs

Patanjali Jam / जैम

Guava Jam / अमरूद जैम - 500 gm MRP - 150 Rs

Patanjali Murabba / मुरब्बा

Amla Murraba / अमला मुरब्बा - 1 kg MRP - 120 Rs

Patanjali Murabba / मुरब्बा

Apple Murraba / सेब मुरब्बा - 1 kg MRP - 140 Rs

Patanjali Murabba / मुरब्बा

Bel Murabba / बेल मुरब्बा - 1 kg MRP - 110 Rs

Patanjali Murabba / मुरब्बा

Harad Murabba / हरड़ मुरब्बा - 1 kg MRP - 115 Rs

Patanjali Soan Papdi / सोन पापड़ी

Chocolate Soan Papdi / चॉकलेट सोन पापड़ी - 250 gm MRP - 160 Rs

Patanjali Soan Papdi / सोन पापड़ी

Elaichi Soan Papdi / इलाइची सोन पापड़ी - 500 gm MRP - 105 Rs

Patanjali Soan Papdi / सोन पापड़ी

Elaichi Soan Papdi / इलाइची सोन पापड़ी - 250 gm MRP - 55 Rs

Patanjali Soan Papdi / सोन पापड़ी

Orange Soan Papdi / ऑरेंज सोन पापड़ी - 250 gm MRP - 55 Rs

Patanjali Sugar/ चीनी

Madhuram Sugar Jaggery Powder / मधुरं शुगर - 1 kg MRP - 60 Rs

Patanjali Broken Cereals / दलिया

Barley Dalia / बार्ले दलिया - 500 gm MRP - 30 Rs

Patanjali Broken Cereals / दलिया

Wheat Dalia / वीट दलिया - 500 gm MRP - 22 Rs

Patanjali Broken Cereals / दलिया

Pushtahar Dalia / पुष्टाहार दलिया - 500 gm MRP - 40 Rs

Patanjali Gram Flour / बेसन

Patanjali Besan / पतंजलि बेसन - 500 gm MRP - 90 Rs

Patanjali Pickle / अचार

Amla Pickle / अमला अचार - 1 kg MRP - 95 Rs

Patanjali Pickle / अचार

Lemon Pickle / नींबू अचार - 400 gm MRP - 65 Rs

Patanjali Pickle / अचार

Tomato Ketchup / टोमेटो केचप - 500 gm MRP - 70 Rs

Patanjali Pickle / अचार

Apple Chutney / एप्पल चटनी - 500 gm MRP - 70 Rs

Patanjali Mustard Oil / सरसों का तेल

Kachi Ghani Mustard Oil (L) / कच्ची घानी मस्टर्ड आयल - 950 gm MRP - 135 Rs

Patanjali Corn Flakes / मक्कई के भुने हुए फुले

Choco Flakes / चोको फ्लेक्स - 125 gm MRP - 55 Rs

Patanjal

if you have any information regarding Job, Study Material or any other information related to career. you can Post your article on our website. Click here to Register & Share your contents.
For Advertisment or any query email us at educratsweb@gmail.com

RELATED POST

1. Union Health Minister approves National Policy for Rare Diseases, 2021
Saturday April 3 2021 : Dr. Harsh Vardhan, Union Health & Family Welfare Minister approved the “National Policy for Rare Diseases 2021” on 30th March 2021. The policy document has been uploaded on the website of Ministry of Health & Family Welfare. For quite some time different stake holders have been demanding for a comprehensive policy for prevention and management of rare diseases. The field of rare diseases is very complex and heterogeneous and prevention, treatment and management of rare diseases has multiple challenges. Early diagnosis of rare diseases is a major challenge owing to a variety of factors that include lack of awareness among primary care physicians, lack of adequate screening and diagnostic facilities etc. There are also fundamental challenges in the research and development for the majority of rare diseases as relatively little is known about the pathophysiology or the natural history of these diseases particularly in the Indian context. Rare diseases are also difficult to research upon as the patients pool is very small and it often results in inadequate clinical experience. Availability and accessibility to medicines are also important to reduce morbidity and mortality associated with rare disease. Despite progress in recent years, there is a need to augment effective and safe treatment for rare diseases. The cost of treatment of rare diseases is prohibitively expensive. Various High Courts and the Supreme Court have also expressed concern about lack of a national policy for rare diseases. To address all these challenges, a very comprehensive National Policy for Rare Diseases 2021 has been finalized by the Ministry of H&FW after multiple consultations with different stakeholders and experts in the area. Draft Policy for Rare Diseases was put in public domain on 13th January 2020 on which comments/views were invited from all stakeholders, general public, organization and States and Union Territories. All the comments received were examined in depth by an Expert Committee constituted by the Ministry. The Rare Diseases Policy aims to lower the high cost of treatment for rare diseases with increased focus on indigenous research with the help of a National Consortium to be set up with Department of Health Research, Ministry of Health & Family Welfare as convenor. Increased focus of research and development and local production of medicines will lower the cost of treatment for rare diseases. The policy also envisage creation of a national hospital based registry of rare diseases so that adequate data is available for definition of rare diseases and for research and development related to rare diseases within the country. The Policy also focuses on early screening and prevention through primary and secondary health care infrastructure such as Health and Wellness Centres and District Early Intervention Centres (DEICs) and through counselling for the high-risk parents. Screening will also be supported by Nidan Kendras set up by Department of Biotechnology. Policy also aims to strengthen tertiary health care facilit

2. 40% of health outcomes can be determined through achieving equity in Social Determinants – IIHMR University on World Health Day
Thursday April 8 2021 : 40% of health outcomes can be determined through achieving equity in Social Determinants – IIHMR University on World Health Day 40% of health outcomes can be determined through achieving equity in Social Determinants – IIHMR University on World Health Day Conducts a talk on ‘Transforming Public Health Education in Developing Nations’ under the SD Gupta School of Public Health · Integration of non-communicable diseases in primary health care · Contribution for health systems and social protection · Building capacities of public health professionals · Incorporating leadership and public health management from right based approach · Strengthening the data of health information systems for a stronger health system Jaipur, 8th April, 2021: There is a dire need for Public Health Education to produce high-quality Public Health professionals. The Evolution for Public Heath that dates to the 19th century marks a conscious shift from medical health to Public Health education. To highlight the prime needs of Public Health as a discipline to be incorporated in the curriculum and must be considered more seriously in Developing Nations, IIHMR University organized a talk on ‘Transforming Public Health Education in Developing Nations. The experts Padmabhushan Dr. Srinath Reddy, President, Public Health Foundation of India and Dr. SD Gupta, Chairman, IIHMR University presented their views. Dr. D. K. Mangal, Dean Research at IIHMR University, moderator of the programme,and summarized their views by stating that there is a need of addressing changing requirements of public health education in India and also in developing nations. Dr. Ashok Agarwal, Trustee, IIHMR, underlining the contribution by IIHMR and the need for Public Health Education, said, “IIHMR has a different approach where the institution began working and thinking about the specialist areas of public health. University has made a tremendous contribution in its research towards Polio Eradication. It has been working on the area of Public Health with an emphasis on implementation level in management practices. IIHMR University has been an apex institution in the field of Public Health, Training, Research and Academics. COVID-19 has exposed the acute need for further research as well as training in Public Health. To address, IIHMR University has recently launched the

3. Health A-Z
Sunday September 8 2019 : Health A-Z Acne Adult ADHD Alcoholism Allergies Alzheimer's Disease Anorexia Nervosa Anxiety Appendicitis Arrhythmia Asthma Attention Deficit Hyperactivity Disorder Autism Back Pain Bipolar Disorder Birth Control Breast Cancer Bronchitis Bulimia Cervical Cancer Childhood Vaccines Cholesterol Chronic Fatigue Syndrome Chronic Kidney Disease Chronic Pain Cold, Flu, and Sinus Colorectal Cancer COPD Crohn's Disease Depression

4. Private Label Cosmetic Products Manufacturer in India
Wednesday July 21 2021 : Private Label Cosmetic Products Manufacturer in IndiaHCP Wellness is the leading urban & innovative Private Label Cosmetic Products Manufacturer in India with the vast experience in the beauty and best-quality private-label Skin care space. HCP Wellness has climbs to the top positions in the beauty market in private label segments among some of the Top Private Label Skin Care Products Manufacturers in India.

5. Ayurvedic products helped to improve the immunity of people during the Corona pandemic
Friday July 23 2021 : The Ministry of AYUSH has developed and launched the AYUSH Sanjivani mobile application to generate data on the acceptance and usage of Ayush advocacies and measures among the population and its impact in the prevention of COVID-19. A cross-sectional analysis of the responses received from approximately 1.47 crore respondents through this App, highlighted that 85.1% of the respondents reported use of AYUSH measures for prevention of COVID-19, among which 89.8% respondents agreed to have been benefitted from the practice of AYUSH advisory. 79.1% of the users responded that the AYUSH measures gave an overall feeling of good health. 63.4% reported improvement in parameters of well being like sleep, appetite, bowel habits, stamina and mental well being. Ministry of AYUSH has prepared a draft scheme namely “Pradhan Mantri VRIKSHA AYUSH Yojna” for promotion of Herbal Cultivation to increase the production of medicinal herbs used in Ayurvedic drugs in near future, which is yet to be approved. This information was given by Minister of State for Ayush Shri Mahendrabhai Munjapara in a written reply in Lok Sabha today. Sources https://www.pib.gov.in/PressReleasePage.aspx?PRID=1738149

6. Health challenges being solved through holistic methods with integrated medicine systems: PM
Friday November 13 2020 : Prime Minister Shri Narendra Modi today dedicated two future-ready national premier Ayurveda institutions to the nation to mark celebration of the 5th Ayurveda Day, here today through video conferencing. The Prime Minister dedicated to the nation the Institute of Teaching & Research in Ayurveda (ITRA), Jamnagar as an Institution of National Importance (INI), and the National Institute of Ayurveda (NIA), Jaipur as a Deemed to be University by the University Grants Commission. Shri Shripad Naik, Minister of State (IC), Ministry of AYUSH, Shri Kalraj Mishra, Governor of Rajasthan, Shri Ashok Gehlot, Chief Minister, Rajasthan, Shri Acharya Devvrat, Governor of Gujarat, and Shri Vijaybhai Rupani, Chief Minister of Gujarat participated virtually. The Prime Minister highlighted the rich legacy of traditional medicine that India has been blessed with. This has been recognized worldwide, more so during the times of the global pandemic of COVID-19 for its beneficial and health and wellness endowing supreme properties, he stated. The Prime Minister stated that the focus has now shifted to prevention and wellness, and the importance of holistic and integrated medicine systems for overall wellness and health of the people. India’s traditional systems of medicine have amply demonstrated to the world the power of Ayurveda. It is now important to develop scientific evidence-based research structures to integrate with the modern knowledge repositories to move ahead in the 21st century. Integrative medicine is the need of the hour, he highlighted. While India has been known as Pharmacy of the World, with evidence-based research, we can take traditional medicine systems and Ayurveda to new heights, he stated. The Prime Minister pointed out that during the Corona period the demand for Ayurvedic products has increased rapidly all over the world. He said exports of Ayurvedic products increased by about 45 percent in September this year compared to the previous year. He added the significant increase in export of spices like turmeric, ginger, considered as immunity boosters shows the sudden boost in confidence in Ayurvedic solutions and Indian spices across the world. He said that during the Corona period, the focus is not only limited to the use of Ayurveda alone but to advance research related to AYUSH in the country and the world. The Prime Minister emphasized that Ayurveda is not an option anymore, but forms a fundamental pillar of the country’s national health policy and health interventions. The Prime Minister congratulated the two premier Ayurveda Institutes and urged them to work in the direction of developing new curriculum to explore and also match the new challenges and opportunities in the field of modern medicine. He urged the Ministry of Human Research and Development (MoHRD) and the University Grants Commission (UGC) to work on this, which shall in turn give a boost to the doctoral and post-doctoral studies. The Prime Minister also urged the private sector and the start-ups industry

7. Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha
Saturday May 15 2021 : Under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production of Indigenous COVID Vaccines. This is being implemented by Department of Biotechnology, Govt. of India at Biotechnology Industry Research Assistance Council (BIRAC), New Delhi. To augument the capacity of Indigenous production of Covaxin under the Mission, theDepartment of Biotechnology, Government of India in April, 2021 provided financial support as Grant to vaccine manufacturing facilities for enhanced production capacities, which is expected to reach more than 10 crore doses per month by September, 2021. As a part of this augmentation plan, capacities of Bharat Biotech Limited, Hyderabad as well as other public sector manufactures are being upgraded with required infrastructure and technology. Financial support is being provided as grant from GoI to the tune of approx. Rs 65 Cr to Bharat Biotech’s new Bangalore facility which is being repurposed to increase the capacity of vaccine production. The following three public sector companies are also being supported to increase the capacity of vaccine production. 1. Haffkine Biopharmaceutical Corporation Ltd, Mumbai-a State PSE under State Govt of Maharashtra. Financial support of Rs. 65 crores as grant from GoI is being provided for this facility to make it ready for manufacturing. The facility will have a capacity of 20 million doses per month, once functional. 2. Indian Immunologicals Limited (IIL), Hyderabad –A facility under National Dairy Development Board is being provided a grant of Rs. 60 crore and 3. Bharat Immunologicals and Biologicals Limited (BIBCOL), Bulandshahr a CPSE under Department of Biotechnology, Government of India is being supported with a grant of Rs. 30 crores to prepare their facility to provide 10-15 million doses per month. Further, Gujarat Biotechnology Research Centre, Department of Science and Technology Govt. of Gujarat along with Hester Biosciences and OmniBRx has also firmed up its discussions with Bharat Biotech to scale up the COVAXIN technology and to produce minimum 20 million doses per month. Technology transfer agreement have been finalized with all manufacturers. About DBT: The Department of Biotechnology (DBT), under the Ministry of Science & Technology, promotes the use and application of biotechnology in the areas of agriculture, healthcare, animal sciences, environment and industry. It is focused on attaining new heights in biotechnology research, shaping biotechnology into a premier precision tool of the future for creation of wealth and ensuring social justice – specially for the welfare of the poor. www.dbtindia.gov.in About BIRAC: Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, set up by Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research

8. Let's Thank Our Healthcare Workers
Monday July 5 2021 : Let's Thank Our Healthcare Workers Last Date Dec 31,2021 23:45 PM IST (GMT +5.30 Hrs) Login to Participate What the world witnessed in the form of the COVID-19 crisis was beyond anybody’s wildest dreams. Though the world beheld chaos unfolds before its eyes in starting 2020, it also saw the unprecedented courage, service, and sacrifice of our doctors, nurses & frontline workers during these tough times. As the second wave of COVID-19 once again tests India's strength & dedication in defeating this virus, we cannot thank our true COVID warriors enough for their spirit, fearlessness, and resolve. Doctors, nurses & frontline workers have isolated themselves away from their families & have been working day and night to battle all the atrocities of the raging pandemic. But are we doing enough for them? The least we can do is make their jobs easier by following COVID Appropriate Behaviour& take out our time to say a heartfelt thank you. Let's make them feel valued. Let’s tell them that they are appreciated every day, but also especially during this unprecedented time, we are all facing together. Let’s hail the selfless work done by the medical professionals in India in dealing with the virus. Though Thank you might sound like a small word against the momentous task they have undertaken, yet let’s make a small start. Join the Thank You Healthcare Workers Initiative & share your message to encourage them to move on to this difficult task of saving the lives during the COVID-19 pandemic.

9. Health and AYUSH Ministers formally launch inter-disciplinary studies involving AYUSH interventions for COVID 19 situation
Friday May 8 2020 : Health and AYUSH Ministers formally launch inter-disciplinary studies involving AYUSH interventions for COVID 19 situation Health Minister Sh. Harsh Vardhan and Minister of State for AYUSH Sh. Shripad Yesso Naik jointly launched clinical research studies on Ayurveda interventions as an add-on to standard care to COVID 19 situation and Ayush Sanjivani application today at New Delhi. AYUSH Minister was participating in the programme through Video Conferencing from Goa. Speaking on the occasion Dr Harsh Vardhan informed that through a graded, pre-emptive and pro-active approach, Government of India is taking several steps for prevention, containment and management of COVID-19. These are being regularly reviewed and monitored at the highest level. Dr Harsh Vardhan said, “India has a history of traditional medicine since long and being the pioneer in the field of Ayurveda, the Ministry of AYUSH is working to address the COVID 19 pandemic problem in the country through clinical studies (prophylactic and add-on interventions) of AYUSH systems. The Union Health Minister said that the Ayush Sanjivani mobile app developed by Ministry of AYUSH will be useful to generate data on acceptance and usage of AYUSH advocacies and measures among the population and its impact in prevention of COVID 19. On this Occasion Shri Shripad Naik said that the Ministry of AYUSH has taken initiatives to address the COVID 19 pandemic problem in the country through clinical studies (prophylactic and add-on interventions) of AYUSH systems and also studying the impact of AYUSH based prophylactic interventions in high risk population. The ministry is also studying the impact of AYUSH advocacies and AYUSH measures for prevention of COVID 19 among the population. Shri Naik futher informed that the Ministry of AYUSH has undertaken four clinical and population based studies to find a better solution to the problem and to assess the role of AYUSH for prevention of the disease. Speaking on this occasion Secretary, Ministry of AYUSH Vaidya Rajesh Kotech informed that the Ministry has setup an Interdisciplinary Ayush R&D Task Force with a group of experts under the chairmanship of Dr Bhushan Patvardhan, Vice Chairmen, University Grant Commission (UGC) to formulate and develop strategies for this initiative. The Joint Secretary, AYUSH Shri P.N.Ranjit Kumar gave presentation and explained in detail about three AYUSH based studies related to COVID-19. He also informed the gathering about the Sanjivni App and explained the benefit of Ayurveda. While talking about the three AYUSH based studies, he gave full details about development of the idea, crowd sourcing, making of the task force, alliance of various institutes like SGPGI, AIIMS, ICMR, CSIR & bringing the idea to reality. The following studies were formally launched in the programme: Clinical research studies on Ayurveda interventions as prophylaxis and as an add-on to standard care to COVID 19: Collaborative clinical studies as a joint initiati

10. Healthium acquires VitalCare Group in U.K. to strengthen its global urology portfolio
Wednesday July 7 2021 : Healthium acquires VitalCare Group in U.K. to strengthen its global urology portfolio Mumbai, India: Healthium, a global player in medical devices, announced that it has acquired VitalCare Group, a manufacturer of urology consumable care products, through its subsidiary Clinisupplies Ltd. This acquisition will help Healthium expand its urology franchise in Europe and other developed markets. Healthium has a diverse portfolio of medical devices and consumables, which includes surgical sutures, needles, a patented arthroscopy portfolio, urology portfolio, hernia meshes, haemostats, gloves, ligation clips, surgical staplers and other wound closure devices. The Company holds 60 patents in India and U.S (including those under process). VitalCare is a manufacturer of urology consumable care products, with relationships with healthcare customers worldwide. The company is headquartered in U.K. with manufacturing operations in China. With the acquisition of VitalCare, Healthium adds to its manufacturing capabilities in urology and boosts its in-house R&D, which will strengthen its presence in the urology segment in Europe and the U.S. Mr. Lewis Calcutt, Managing Director, VitalCare will continue with the company, building on its global presence and creating a truly differentiated product portfolio. Commenting on the acquisition Mr. Anish Bafna, MD & CEO, Healthium Medtech said, “It is our ambition to cater to needs of India and the world when it comes to quality medical devices and consumables. We continue to invest in R & D as we aim to make products that address unmet needs of patients and medical professionals. The acquisition of VitalCare will bring together global talent, diverse cultures, differentiated expertise, strengthen our product portfolio and presence in Urology care to drive continuous value for our customers. The combined leadership and synergies in offerings from both companies will further strengthen distribution, offer more choices to our customers and enable us to deliver better patient care worldwide.” Mr. Paul Cook- CEO Clinisupplies also added, “Given the rapid changes we are witnessing in the global healthcare system, the time is right for both companies to join forces and take on the larger market opportunity. The acquisition will help us expand our footprint in Europe and U.S. Together, we will continue to focus on bringing forward best in class and innovative solutions that will continue to redefine urology care.” Mr. Lewis Calcutt, Managing Director, VitalCare said, “We are extremely excited about our association and are looking forward to expanding our urology care portfolio under the leadership of Healthium. This relationship will be a strong contributor to our growth and give us access to attractive geographies.” About Healthium Healthium is a global player in Medical Devices focused

11. New Healthcare Scheme for Covid-19 Victims
Tuesday September 15 2020 : There is provision made under ‘Pradhan Mantri Garib Kalyan Package for Health Workers Fighting COVID-19. This is a Central Sector scheme. The scheme provide an insurance cover of Rs. 50 lakh to healthcare providers, including community health workers, who may have to be in direct contact and care of COVID-19 patients and who may be at risk of being impacted by this. It will also include accidental loss of life on account of contracting COVID-19. The scheme also covers private hospital staff/ retired/volunteer/ local urban bodies/contract/daily wage/ ad-hoc/outsourced staff requisitioned by States/ Central hospitals/autonomous hospitals of Central/States/UTs, AIIMS & INIs/ hospitals of Central Ministries drafted for COVID-19 related responsibilities. The insurance provided under this scheme would be over and above any other insurance cover being availed of by the beneficiary. In addition for treatment of those affected by COVID, Government is implementing Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) to provide health cover of Rs. 5 lakh per family per year for secondary and tertiary care hospitalization to around 10.74 crore poor and vulnerable families (approx. 50 crore Individuals) as per Socio-Economic Caste Census (SECC) data. To effectively cover AB-PMJAY beneficiaries for testing and treatment of COVID-19, packages for ‘Testing for COVID-19’ and ‘Treatment of COVID-19’ have been notified. The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here today. Sources https://pib.gov.in/PressReleseDetail.aspx?PRID=1654457

12. Columbia Pacific Communities (CPC) and Fortis Healthcare launch #ReachOut, a mental health initiative supporting India’s elderly amid the second COVID wave
Tuesday May 18 2021 : Columbia Pacific Communities (CPC) and Fortis Healthcare launch #ReachOut, a mental health initiative supporting India’s elderly amid the second COVID waveColumbia Pacific Communities (CPC) and Fortis Healthcare launch #ReachOut, a mental health initiative supporting India’s elderly amid the second COVID wave The ten-day social media campaignencourages senior citizens to seek help for their mental health allowing them to deal with trauma, hopelessness and stress. Mumbai, May 17, 2021:With India battling the second wave of COVID-19, people of all ages are experiencing miasma, hopelessness and are unable to process the whirlpool of negative news surrounding them. Seniors in particular are feeling increasingly anxious and overwhelmed by the situation, and often tend to shy away from opening up about their mental health for the fear of being judged. While the pandemic has largely focused on physical health (the importance of hygiene and sanitisation, building one’s immunity), there has not been much focus on the mental distress caused by the pandemic. To help senior citizens address their mental health issues, Columbia Pacific Communities, India’s largest senior living community operator has partnered with Fortis Healthcare, one of India’s most reputed healthcare service providers to launch a mental wellness initiative titled #ReachOut. The objective of the10-day social media led initiative is to provide senior citizens with free and easy access to experts who can provide them with counselling, therapy andno-judgement, confidential conversations. Mohit Nirula, CEO, Columbia Pacific Communities, said, “Even after a year of the pandemic, mental health is a topic that is not discussed much. We believe that mental wellness is an integral part of overall wellness, a primary driver of positive ageing, and have always created space and opportunities for our residents to retain charge of their lives. In these difficult times, when seniors staying on their own are feeling lonely, isolated, overwhelmed and hopeless, this initiative in association with Fortis Healthcare, one of India’s most reputed healthcare service providers, will encourage them to open up and reach out for help.” The objective of this initiative by Columbia Pacific Communities is to stand with India’s senior citizensduring this difficult time and provide them a safe space encouraging them to ask for help. ‘Fortis Stress Helpline’ by Fortis National Mental Health Program, is a free 24x7 helpline providing support, crisis intervention and guidance by psycholog

13. 11 Proven Health Benefits of Garlic
Tuesday April 20 2021 : 11 Proven Health Benefits of Garlic11 Proven Health Benefits of Garlic Garlic Contains Compounds With Potent Medicinal Properties Garlic Is Highly Nutritious But Has Very Few Calories Garlic Can Combat Sickness, Including the Common Cold The Active Compounds in Garlic Can Reduce Blood Pressure Garlic Improves Cholesterol Levels, Which May Lower the Risk of Heart Disease Garlic Contains Antioxidants That May Help Prevent Alzheimer’s Disease and Dementia Garlic May Help You Live Longer Athletic Performance Might Be Improved With Garlic Supplements Eating Garlic May Help Detoxify Heavy Metals in the Body Garlic May Improve Bone Health Garlic Is Easy to Include in Your Diet and Tastes Absolutely Delicious

14. The contract manufacturing market for live biotherapeutics and microbiome products -
Friday April 23 2021 : The contract manufacturing market for live biotherapeutics and microbiome products - Roots Analysis has done a detailed study on Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html Key Market Insights The microbiome therapies pipeline features 260 drugs under evaluation across different phases of development; contract service providers have become an integral part of the supply chain owing to their technical expertise. Presently, over 25 firms across the globe claim to possess the required know-how and infrastructure to offer contract manufacturing services for live biotherapeutic products and microbiome therapies The market is fragmented, featuring the presence of established players and mid-sized firms across different global regions, with capabilities to manufacture aerobic and / or anaerobic strains, at varying scales of operation Most of the installed, global live biotherapeutic contract manufacturing capacity presently belongs to dedicated large and mid-sized CMOs, accounting for over 90% of what is available across various geographies Future growth of the market is likely to be driven by increased demand for these therapeutics; we expect the service-based revenues to grow at an annualized rate of over 46% in the coming decade In the long-term, the projected market opportunity is anticipated to be well distributed across different types of formulations, sizes of contract service providers and geographical regions For more information, please visit https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html Contact Details Gaurav Chaudhary +1 (415) 800 3415 gaurav.chaudhary@rootsanalysis.com

15. Ministry of Tourism organises a webinar titled “Yoga for Immunity and Respiratory Health”
Saturday June 19 2021 : Ministry of Tourism and its domestic as well as overseas offices have already initiated weeklong programmes for celebration of International Day of Yoga 2021. Based on this year’s theme given by Ministry of Ayush “Be With Yoga Be At Home”. The Ministry of Tourism organised a webinar titled “Yoga for Immunity and Respiratory Health” in association with Isha Foundation today , Saturday the 19th June 2021. The webinar started in guidance of Sadhguru Jaggi Vasudevji, a multi-facet personality famous world-wide for its Isha Foundation dedicated to raising human consciousness and fosters global harmony through individual transformation. Sadhguruji explain about the importance of yoga and its benefits and later explained the Simha Kriya in detail. Simha Kriya, a simple but powerful yogic practice to improve immunity, strengthens the respiratory system and enhances lung capacity. A volunteer from Isha foundation demonstrated the kriya. Ms. Mahima Chopra from Isha Foundation also explained about the Simha Kriya, Sashtanga Makarasana, do & don’ts while following the kriya. On International Day of Yoga that on 21st June 2021, the Ministry of Culture in association with the Ministry of Tourism have organised live streaming celebration of Yoga from 30 sites across India identified by the Ministry of Culture following covid protocols strictly. Culture is increasingly an important element of the tourism product, which creates distinctiveness in a crowded global marketplace. At the same time, tourism provides an important means of enhancing culture and creating income which can support and strengthen cultural heritage, cultural production and creativity. Creating a strong relationship between tourism and culture can therefore help destinations to become more attractive as well as more competitive as locations to live, visit, work and invest in. In the presence of Union Minister of State for Tourism & Culture (I/C)Shri Prahlad Singh Patel and Gurudev Sri Sri Ravi Shankar ji, on Monday, the 21st June 2021, the Ministry of Tourism would be organising one more webinar “Yoga: The way of life” at 1200 hrs . To join the webinar, please register at: https://digitalindia-gov.zoom.us/webinar/register/WN_8bYtqL-fSKWjFdtrcuJCwQ For more information follow Incredible India on : Instagram - https://instagram.com/incredibleindia?igshid=v02srxcbethv Twitter - https://twitter.com/incredibleindia?s=21 Facebook - https://www.facebook.com/incredibleindia/ &nbs

16. Launch of New, Impactful, Immunity Boosting Products From The Forest Fresh, Organic Range on Tribes India
Monday December 7 2020 : Continuing to expand its product range and make it more attractive, while enabling millions of tribal enterprises access to larger markets, Tribes India has added 46 more new tribal products, mainly in the Forest Fresh and Organic range, into its catalogue this week. TRIFED has added a large number of immunity boosting products, produce in the Forest Fresh and Organics range and tribal arts and handicrafts to its Tribes India range in the last month. All the new products introduced in the past few weeksare available in 125 Tribes India outlets, Tribes India mobile vans and also on online platforms such as the Tribes India E-marketplace (tribesindia.com) and e-tailers. Speaking on the occasion, Shri Pravir Krishna, Managing Director, TRIFED said, “Tribes India endeavours to impact and transform tribal lives and improve their livelihoods.Go Vocal for Local Go Tribal is the mantra that TRIFED goes by as it works in benefitting tribals and improving their livelihoods across the country.Introducing these new products sourced from tribes all over India into the range is yet another step in this direction. Sourced from different parts of the country, among theproducts launched today, include healthy tasty cookies in various flavours such as coconut, til, almond, besanand butter, made by Oraon tribes of Jharkhand. 10 products in the organics products range have been sourced from the Malayali tribe in Tamil Nadu. These include organic whole bajra, organic horsegram, organic millet biscuits, organic millet rice varieties, turmeric powder and a herbal soap. From the Khond tribes of Odisha, 5 products have been sourced this week. These include organic agarbattis made from sal resin, organic methi powder pounded by more than 300 tribal women from Odisha, sunthi (dry ginger) powder, dhania powder and panchphutana (tadka / garnish masala). Natural, forest fresh honey direct from the Maria, Mudia and Gond tribes of Chhattisgarh have also been included. This honey is pure and has no added ingredients. Van Tulsi Honey, which has been certified is a highlight of today’s launch. Other products includeDesi ghee, turmeric essential oil, and desi rice and sweet potato chips. 6 products were included from the state of Rajasthan. These are essentially herbal products, amla juice, and khajur basket and saunf. From Ahmedabad, 10 Ayurvedic products have been included. These include Amalakki powder, harda powder, rasayan powder, brahmi powder, Ashwagandha powder and Amrutha. All these are immunity boosting, organic produce sourced from various tribes of Gujarat. Go Vocal for Local Go Tribal is the mantra that TRIFED under Ministry of Tribal Affairs goes by as it works in benefitting thetribals and their livelihoods across the country. The recently launched Tribes India e-marketplace, India’s largest handicraft and organic products marketplaceshowcases tribal produce and handicrafts, making them accessible to customers across the country.

17. MyGatebrings affordable health insurance scheme for support staff of its 3 million households
Tuesday August 24 2021 : MyGatebrings affordable health insurance scheme for support staff of its 3 million households Users can now purchase a daily cash benefit from Rs. 500 to Rs. 3000, with premium starting at Rs.155 per annum, which will be particularly useful to maids, drivers, cooks or nannies Mumbai, 24 August 2021: The pandemic has laid bare the tenuous financial situation of India’s lower income groups, such as those employed as daily help. Simultaneously, there is growing evidence of a willingness among gated community residents to support their staff; for example, the MyGate Trust Circle report revealed that 76.04% of residents are now more likely to provide monetary assistance to their daily help as compared to pre-Covid times. Taking a cue from this behavioural shift, MyGate now enables its 3 million users to purchase a hassle-free Group Health Insurance cover. This comes at a low cost and is relevant to their domestic help, such as maid, nanny, cook or driver. MyGate’s members can buy a group health cover that allows beneficiaries to claim daily cash benefit (Hospi Cash) for hospital admissions ranging from Rs.500 per day to Rs. 3000 per day for 30 days in a year with no deductibles. The policy premium starts at Rs. 155 and goes up to a maximum of Rs. 900. The policy is available for 12 months for those aged 18 years to 65 years. This cover is underwritten by Care Health Insurance. “It has been heartening to learn of growing empathy toward support staff, as illustrated in the MyGate Trust Circle report. It is clear that gated community residents are looking for meaningful ways to give more to their support staff and we believe that Hospicash is a valuable benefit they can provide their maid, driver or nanny with” said Abhishek Kumar, COO and Co-founder,MyGate. Since March 2020, MyGate has made the health and safety of its users and the broader gated community ecosystem a priority. For example, it has launched more than 10 features specifically to combat the coronavirus, such as Leave at Gate, Temperature & Mask Check and Quarantine at Home. The organisation also organised mass RT-PCR and vaccination drives within gated communities and made the facility open to support staff as well. About MyGate Founded in 2016, MyGate is the largest community app in the country, simplifying urban living of over 3 million homes in 20,000+ housing societies. It was ranked #4 on YourStory’s list of India’s Most Disruptive Start-ups in December 2019 and one of India’s coolest start-ups by Business Today in 2019. MyGate was founded by Vijay Arisetty, an ex- IAF pilot (Shaurya Chakra awardee), Abhishek K, former VP at Goldman Sachs, and ShreyansDaga, former project head at Oracle and Digit. For more information, please see https://mygate.com/

18. Quess Corp launches new vertical to transform Healthcare Services in India
Tuesday August 24 2021 : Quess Corp launches new vertical to transform Healthcare Services in India Mumbai, India. August 23, 2021. Quess Corp, India’s leading business services provider, today announced the launch of its new healthcare vertical to address the shortage of healthcare professionals. The vertical aims to provide trained healthcare manpower, home care solutions, and end-to-end hospital management services by identifying, training & upskilling healthcare professionals through a network of accredited medical training institutes, enabling quick & on-demand deployment. Quess Corp has signed an MoU with the Association of Healthcare Providers (India) (AHPI), a not for profit representative body of healthcare providers, to evangelize formalization of training and staffing services for healthcare professionals and create a talent marketplace for private and public healthcare institutions. The collaboration aspires to create a pipeline of trained paramedical and healthcare service professionals through a proposed hire-train-deploy model, besides building a digital pool of highly skilled, experienced, ready-to-hire doctors across India. In addition to creating an organized demand and supply support service for healthcare manpower such as nurses, paramedics, doctors, phlebotomists, and lab technicians, the collaboration will also enable corporates to set up safer workspaces with adequate medical facilities, and to train candidates with endorsements from reputed domestic and international accreditations. Through this alliance, Quess Corp and AHPI plan to jointly work towards industry advocacy in critical areas of staffing and healthcare manpower management. Mr. Guruprasad Srinivasan, Chief Operating Officer-India Region, Quess Corp, said, “The healthcare industry in India has witnessed increasing staffing demands since the advent of the pandemic. There are nearly 600 investment opportunities worth USD 32 Billion in the hospitality/medical infrastructure sub-sector on Indian Investment Grid (IIG). We look forward to effectively bridging the talent gap and challenges in the Indian healthcare infrastructure, which was largely brought to the fore during the pandemic.” Dr. Naresh Shetty, President, Quess Healthcare said, “In India, the healthcare segment faces dismaying challenges with an acute shortage of skilled manpower to the tune of six million paramedics today. We hope to bridge this gap and indisputably impact skill development and knowledge enhancement of the healthcare sector, which is the absolute need of the hour. Through tech-enabled skilling and access to a talent pool of trained professionals, we want to empower healthcare providers to cater to a wide public reach while providing access to quality healthcare for all.” Dr. Alex Thomas, President of AHPI said, “Having been associated with both organisations for many years, I

19. Fortis Healthcare hands over cheque of Rs 2.5 crore to ICMR from CSR fund in the presence of MoS Health and Family Welfare Shri Ashwini Kumar Choubey
Sunday September 27 2020 : Private sector medical service provider Fortis Healthcare handed over a cheque of Rs 2.5 crore to ICMR in the presence of Minister of State for Health and Family Welfare Shri Ashwini Kumar Choubey in his office. Fortis Healthcare’s MD and CEO Dr Ashutosh Raghuvanshi, senior Vice President (Corporate Affairs and CSR) Manu Kapila, SRL’s CEO Anand Kumar presented the cheque to Indian Council of Medical Research (ICMR) Director General Prof (DR) Balram Bhargav and senior financial advisor Rajiv Roy. At the event, Shri Choubey said that the ICMR has “established an outstanding parameter in the field of research”. Not only in India, this institute one of the best research institute in the world. Scientists have worked tirelessly day and night since day one of Covid-19 pandemic.” He also said “the Fortis Hospital has done a commendable job and I am sure this would inspire many.” Sources https://pib.gov.in/PressReleseDetail.aspx?PRID=1659305

20. The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, claims Roots Analysis
Monday August 2 2021 : The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, claims Roots AnalysisReport Keywords - CAR-T Cell, Therapies Market, Rootsanalysis, Report, Biotech Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings. Given their ability to selectively direct a cell mediated immune response against cancer cells and, thereby, offer prolonged periods of disease remission, several CAR-T cell therapies provide a promising therapeutic strategy for advanced stage cancers and are expected to achieve blockbuster status. With four approved products and many candidate therapies under evaluation for the treatment of multiple disease indications, the CAR-T cell therapy market is characterized by a healthy and growing pipeline. Further, with lucrative financial support and notable increase in partnerships, the CAR-T-cell therapies market is abuzz with activity. To order this 795+ page report, which features 165+ figures and 270+ tables, please visit https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html Key Market Insights Over 755 CAR-T cell therapies are currently approved / under development Close to 40% of the aforementioned candidates are in preclinical and discovery stages, while more than 25% are being evaluated in clinical stages (phase I/II and above). Examples of late-stage clinical candidates include bb2121, CD123/CLL1 CAR-T CD19 CAR-T and LCAR-B38M CAR-T / JNJ-68284528. Currently, the focus is on developing product candidates to treat various types of cancers Over 95% of the products in the development pipeli

21. Why do new waves happen? Member (Health), NITI Aayog answers
Tuesday June 22 2021 : “There are countries where even the second wave has not occurred. If we do what is required and do not indulge in irresponsible behaviour, then outbreak should not occur. This is a simple epidemiological principle.” Dr. V.K. Paul, Member (Health), NITI Aayog was explaining the reasons behind emergence of new pandemic waves and how it can be controlled or even avoided by following COVID appropriate behaviours and taking measures such as vaccination. He was addressing the Union Health Ministry's media briefing on COVID-19, held at National Media Centre, PIB Delhi today. Why do new waves happen Dr. Paul said that there are four elements leading to the formation of a new wave. Behaviour of the virus: The virus has the capacity and ability to spread Susceptible host: Virus keeps looking for susceptible hosts for it to survive. So, if we are not protected either via vaccination or by previous infection, then we are a susceptible host. Transmissibility: The virus can become smart enough where it mutates and becomes more transmissible. The same virus which used to infect three hosts becomes capable of infecting 13! This factor is unpredictable. No one can pre-plan to fight such mutations. The change of the very nature of the virus and its transmissibility is an X factor and no one can predict when and where it may happen. Opportunity: ‘Opportunities’, which we give to the virus to infect. If we sit and eat together, crowd, sit in closed areas without masks, then the virus gets more opportunities to spread. A call to do what is in our hands The NITI Aayog Member reminds us what is in our hands. “Out of the above four, two elements– Susceptibility and Opportunities for infection are totally under our control whereas the other two - Behaviour of the virus and Transmissibility, cannot be predicted or controlled. So, if we are protected and ensure we are not susceptible, then the virus will not be able to survive. We can control the susceptibility by wearing a mask or getting vaccinated. Hence if we decrease opportunities by following COVID Appropriate behaviour and decrease susceptibility to infection, then a third wave will not occur.” Dr. Paul also called for collective efforts of the citizens as well as the system in order to stop another wave. “Some of these require individual efforts, while some others such as isolation of clusters, contact tracing, ensuring testing capacity and building awareness require the system to act.” “Decision to open schools has to be taken very cautiously” Speaking about easing restrictions and reopening of schools, Dr. Paul said that the decision has to be taken cautiously and that we should take risks only when we are protected. “School is a crowd, a medium or large gathering, which gives opportunity for virus to infect. So, we should take that risk only when we are rather better protected, vir

22. World Health Organisation applauds India for Fitness Ka Dose Aadha Ghanta Roz campaign; celebrities from all walks support the movement
Thursday December 10 2020 : The clarion call made by Prime Minister Shri Narendra Modi to all Indians of Fitness Ka Dose Aadha Ghanta Roz has received praise from the World Health Organisation. In a tweet, WHO said, "WHO applauds India's initiative on promoting physical activity through its campaign Fitness Ka Dose Aadha Ghanta Roz." The campaign launched as part of the nation-wide Fit India Movement by Union Minister of Youth Affairs and Sports Shri Kiren Rijiju on December 1, has gained the support of celebrities from different fields - Bollywood, sportspersons, writers, doctors, fitness influencers, among others, who have enthusiastically urged Indians to follow the basic mantra of 30 minutes of fitness every day. Badminton World Champion and Olympic Medalist PV Sindhu tweeted "Fitness is a huge part of my life and this is the chance for everyone to come together and unite for this great movement!" Writer Chetan Bhagat further added that one’s fitness has a “profound effect on immunity, mood, health and overall wellness in life.” And thus, is great that all of us can do. Lifestyle and wellness expert Luke Coutinho agreed to their thoughts and added “Working out for just 30 minutes a day can go a long way in contributing to your fitness and overall health levels! Thank you so much @narendramodi & @KirenRijiju for making me a part of this wonderful initiative!” ISSF World Cup Gold Medalist shooter Apurvi Chandela also supported their view and tweeted “Do something today, that your future self will thank you for!! A minimum of 30 minutes of daily exercise can bring about many positive changes in your body, mind and soul. #NewIndiaFitIndia #FitIndiaMovement.” They were also joined in their call by two time Olympic Bronze medalist & wrestler Sushil Kumar, Olympic Bronze Medalist shooter Gagan Narang, Former India Cricketer Suresh Raina, Paralympic Silver Medalist Deepa Malik, sprinter Hima Das, Commonwealth Gold medallist Manika Batra, actor Anil Kapoor, TV actress Saumya Tondon, cricketer Mithali Raj, CWG Silver Medalist Manish Kaushik, writer Chetan Bhagat, among many others.

23. Karnataka ASHA: Demonstrating the true spirit of a Social Health Activist
Friday July 3 2020 : Karnataka ASHA: Demonstrating the true spirit of a Social Health Activist Annapurna is an ASHA working in Tunganagar in Shivamogga District, Karnataka. She covers a population of 3000 in the slum area and has been working there since 2015, when urban ASHA were introduced as part of the National Health Mission. One of her key tasks as part of COVID-19 activities is to conduct household surveys. Karnataka’s 42,000 ASHAs have emerged as a crucial pillar in the State’s success in combating COVID-19. They have been actively participating in the COVID-19 household surveys and screening inter-state passengers, migrant workers, and others in the community for symptoms of COVID-19. Recognizing the increased vulnerability of certain population groups to COVID-19, in a one-time survey to identify households with the elderly, persons with co-morbidities, and immuno-compromised individuals, about 1.59 crore households were covered. ASHAs regularly monitor such high-risk groups in their area with periodicity of follow-up visits varying from once a day in the Containment Zones to once very 15 days in other areas. They also visit the houses of persons expressing complaints of ILI/SARI symptoms, and high-risk individuals who have called the State Health Department helpline numbers. Uniquely, ASHAs are part of the Rural Task Force headed by Panchayat Development Officer (PDO) at the Gram Panchayat level for addressing public grievances on both COVID-19 and non COVID-19 related services. Urban ASHAs have been on the forefront of dissemination of various awareness activities in the Fever clinics and Swab Collection Centres in Urban areas. They have also actively screened cases of ILI and SARI in the urban areas. They are also part of the screening teams at the International and Interstate check-posts. Glimpses from Karnataka: ASHAs at work against COVID-19

24. Webinar on Harmonization of Regulation of Standardization of Traditional Medicinal Products of Brics Countries
Friday June 4 2021 : Ministry of AYUSH organized a Webinar on Harmonization of Regulation of Standardization of Traditional Medicinal Products of Brics Countries under India’s BRICS Chairship of 2021recently. The event was attended by the eminent experts and stakeholders from the field of Traditional Medicine from India, China, South Africa, Russiaand Brazil. Ministry of AYUSH had proposed to organise the said webinar during the “First meeting of BRICS Sherpas” held on 24-26 February 2021 as a part of India’s Chairship of BRICS 2021 which was agreed by the Member States. Ministry of AYUSH had also hosted the virtual meeting of the “BRICS Experts in Traditional Medicines” 25th March 2021. Dr. Manoj Nesari, Adviser (AYUSH), Ministry of AYUSH, Government of India chaired the event and delivered opening remarks. While briefing about the Webinar, Dr.Nesari emphasized on India’s BRICS 2021 priorities and deliverables in the field of Traditional Medicine with the aim of enhancing and strengthening BRICS collaboration. The proposal from India included MoU on BRICS Cooperation in Traditional Medicines and constitution of BRICS Forum on Traditional Medicine (BFTM). He underlined the need for harmonisation of regulation of standardization of traditional medicinal products amongst BRICS countries. Initiatives taken by India for the mitigation of COVID19 through AYUSH system of medicine were also highlighted upon. During the first session of the Webinar, Country presentations were made by the representative of BRICS countries on Drug regulations; Service Standards & Regulations; Pharmacopeia of Traditional Medicine in their respective countries. “AYUSH regulations and pharmacopoeial standards”; “Pharmacopoeia of Indian Traditional systems of Medicine - An overview and “Standardization and Regulation of AYUSH Healthcare Services”were made byIndian side. During the second session of the Webinar, discussionwas held among the industry stakeholders from the field of Traditional Medicine from BRICS Countries. Comprehensive presentations were made by the representatives of Traditional Medicine industry from India and China. The experts and stakeholders of Traditional Medicine from the BRICS countries expressed their appreciation and extended cooperation and support for the India’s efforts and initiatives taken for the promotion of Traditional Medicine globally including for BRICS countries. Sources https://www.pib.gov.in/PressReleasePage.aspx?PRID=1724288

25. Yoga and Health
Sunday September 8 2019 : The word “health” originates from the root word “whole.” If one has to experience a sense of wholeness, it is important that besides the body and mind, one’s energy also functions at a certain level of intensity. If your energy is in proper balance and full flow, you will be in perfect health physically and psychologically. The focus of modern medicine has been the body’s chemistry. For every problem in your body, you ingest a medicine – which is a chemical – to arrive at some balance. This chemical may address a particular health issue, but it also has a side-effect. For the side-effect, there is an antidote. For the antidote, there is another antidote. This becomes an endless chain. Yoga however, addresses health in a very fundamental way. Whatever is happening with your body chemistry is controlled by the way your energies function. A proper yogic practice is about going to the foundations of your energy system to activate and establish it in such a way that your body and mind naturally function at their full potential. One important point is to distinguish between infectious and chronic diseases. Infections are an external invasion. You must go to the doctor. Don’t meditate on it! But 70% of ailments on the planet are chronic – they manifest from within. The root cause for these is always within. If people are willing to do a few simple practices to balance and activate their system, they can definitely be free of chronic ailments. If you look at your body, you were not born the way you are right now. You started as just two cells in your mother’s womb, then you came out as a baby and now your body is fully grown. How did all this happen? No one stretched your body from the outside! That which is the basis of creation, that which you refer to as the creator is functioning from within you. The manufacturer of the body is within. If you have a repair job to be done, would you like to go to the manufacturer or the local mechanic? If you have lost the manufacturer’s ID, you go to the local mechanic. Yoga is an exploration of the inner terrain and to find the source of our making. When you know the manufacturer and have access to him, you would definitely go to the manufacturer. Yoga means going back to the manufacturer. If you allow the source of creation to function, whatever needs to be fixed will happen effortlessly.

26. COVID Pandemic has impacted to the Mental Health: IIHMR University Study
Wednesday July 21 2021 : Mental Illness is the second leading cause of disease burden in India – Dr. SD Gupta COVID Pandemic has impacted to the Mental Health: IIHMR University Study Editor’s Synopsis – · Mental Health is the second leading cause of disease burden in India · One in Seven Indians were affected by mental disorders of varying severity in 2017 and COVID must have made this ratio worst · 1140 psychiatrists, counselors, and social workers trained to assess the psychological health of people with COVID infected, older people living alone and children · Stop watching/reading COVID news to mental wellbeing - Prof. Vimal Sharma of University of Manchester India | 21st July, 2021 IIHMR University in its series of PUBLIC HEALTH AND MENTAL WELLBEING DISCUSSION SERIES: ISSUES, CHALLENGES, AND SOLUTIONS AMID COVID 19 organized a webinar on ‘Mental Health – A Global Public Health Challenge’. The eminent speakers from the University of London, University of Manchester, and IIHMR University shared their research work and thoughts on the spectrum of mental health during COVID, and coping strategies. The key speakers were – Prof. Mohammed Abou – Saleh, Professor of Psychiatry, St. George’s, University of London; Prof. Vimal Sharma, Professor of Global Mental Health Research, University of Manchester and Dr. S D Gupta, Chairman of IIHMR University. Dr. S D Gupta, Chairman of IIHMR University said, “Mental Illness is the second leading cause of disease burden in India. And COVID has made this ratio worst with a sudden impact with various factors affecting mental well-being. People were worried about livelihood but the massive impacts on mental health were due to factors such as lockdown, migration, job losses, deaths of family members, work from home, household violence, and study from home due to COVID. Patients who were having mental health issues before COVID, how they managed without non-availability of mental health care during COVID times.” As per Lancet Psychiatry 2020 report, One in every seven Indians were affected by mental disorders of varying severity in 2017. The proportional contribution of mental disorders to the total disease burden in India has almost doubled since 1990. Substantial variations exist between the states in the burden from different mental disorders and in their trends over time. With the COVID pandemic, this ratio of mental disorders in the Indians must have made the worst impact. CO

27. Tele-Medicine Platform for Health Care Delivery
Friday September 18 2020 : Public health is a state subject. Under the National Health Mission (NHM), support is being provided to States/UTs to strengthen their healthcare systems including Tele-consultation services based on requirements posed by the States in their Programme Implementation Plans (PIPs). eSanjeevani Telemedicine solution developed by CDAC-Mohali is being rolled out under Ayushman Bharat – Health & Wellness Centres program. Under Ayushman Bharat, 1.5 lakh Sub Health Centres (SHCs) and rural and urban Primary Health Centres (PHCs) across the country are being transformed by December 2022 as Health and Wellness Centres (AB-HWCs) with an aim to provide Comprehensive Primary Health Care (CPHC) that includes preventive and health promotion at the community level with continuum of care. The state- wise details of funds approved under NHM for Tele-consultation for FY 20-21 are given below: State-wise details of funds approved under NHM for Tele-consultation at Ayushman Bharat Health and Wellness Centres Sl. No. State Total Amount Approved for Tele-Consultation in FY 20-21 (Rs. in lakh) as on 15.09.20 1 Andaman & Nicobar Islands 0 2 Andhra Pradesh 69.55 3 Arunachal Pradesh 63.2 4 Assam 33.84 5 Bihar

28. Primary Health Centres (PHCs)
Friday September 18 2020 : Under the National Health Mission (NHM), Primary Health Centre (PHC) are established to cover a population of 30,000 in rural areas and 20,000 in hilly, tribal and desert areas. PHCs are established to cover defined population. As per the Rural Health Statistics-2019, as on 31.03.2019, a total of 24,855 rural PHCs and 5,190 urban PHCs have been functional in the country. State-wise details including for Rajasthan are given below: NUMBER OF PRIMARY HEALTH CENTRES (PHCs) FUNCTIONING IN RURAL AND URBAN AREAS (As on 31.03.2019) Sr. No. State / UT PRIMARY HEALTH CENTRES (PHCs) Rural Urban Total 1 Andhra Pradesh 1,145 364 1,509 2 Arunachal Pradesh 143 4 147 3 Assam 946 55 1,001 4 Bihar 1,899 95 1,994 5 Chhattisgarh 792 45 837 6 Goa 24 0 24 7 Gujarat 1,476

29. Adequate health infrastructure and health facilities set up for COVID-19 management
Sunday May 10 2020 : Adequate health infrastructure and health facilities set up for COVID-19 management Adequate health infrastructure and health facilities have been identified and set up for COVID-19 management in the country. The public health facilities dedicated for COVID-19 case management are categorised into three categories as below: Category I Dedicated COVID Hospital (DCH) - The Dedicated COVID Hospitals are hospitals that offer comprehensive care primarily for those who have been clinically assigned assevere. These hospitals shall have fully equipped ICUs, Ventilators and beds with assured Oxygen support. These hospitals shall have separate areas for suspect and confirmed cases. The Dedicated COVID Hospitals shall serve as referral centres for the Dedicated COVID Health Centres and the COVID Care Centres. Category II Dedicated COVID Health Centre (DCHC) - The Dedicated COVID Health Centres are hospitals that offer care for all cases that have been clinically assigned as moderate. The Dedicated COVID Health Centresshall have separate areas for suspect and confirmed cases. These hospitals shall have beds with assured Oxygen support. Every Dedicated COVID Health Centre is mapped to one or more Dedicated COVIDHospitals. Category III Dedicated COVID Care Centre (DCCC) - The COVID Care Centres shall offer care only for cases that have been clinically assigned as mild or very mild cases or COVID suspectcases. These are makeshift facilities which may be set up by the States/UTs in hostels, hotels, schools, stadiums, lodges etc., both public and private. These facilities shall have separate areas for suspected and confirmed cases.Every Dedicated COVID Care Centre is mapped to one or more Dedicated COVID Health Centres and at least one Dedicated COVID Hospital for referral purpose. As on 10/05/2020, 7740 facilities in 483 districts have been identified in all the States/UTs that include hospitals and facilities of the State/UT Govts as well as the central Govt. There are 656769 isolation beds, 305567 beds for confirmed cases, 351204 beds for suspected cases, 99492 Oxygen supported beds, 1696 facilities with Oxygen manifold and 34076 ICU beds. All the States/UTs have been requested by Government of India to notify and upload the assigned three types of COVID dedicated facilities on their websites for public information. 32 States/UTs have already uploaded the information on their websites/public information platforms and the rest are in the process of doing the same. In view of the need for further increasing the testing capacity for COVID-19 at National Centre for Disease Control (NCDC), the procurement of a high throughput machine as per the recommendations of Empowered Group 2 was approved. The Cobas 6800 testing machine has been successfully installed at NCDC now. NCDC is providing support for testing of samples from Delhi, NCR, Ladakh, J&K and various other states, as per need. Presently t

30. Pradhan Mantri Garib Kalyan Package Insurance Scheme for Health Workers Fighting COVID-19 extended for another 6 months
Tuesday September 15 2020 : The ‘Pradhan Mantri Garib Kalyan Package Insurance Scheme for Health Workers Fighting COVID-19’ was announced on 30 March 2020 for a period of 90 days. This was extended for a further period of 90 days i.e. up to 25th Sept, 2020. The scheme has now been extended for another 180 days i.e. 6 months. This Central Sector Scheme provides an insurance cover of Rs. 50 lakh to healthcare providers, including community health workers, who may have to be in direct contact and care of COVID-19 patients and therefore at risk of being infected. It also includes accidental loss of life on account of contracting COVID-19. The scheme also covers private hospital staff/ retired/volunteer/ local urban bodies/contract/daily wage/ ad-hoc/outsourced staff requisitioned by States/ Central hospitals/autonomous hospitals of Central/States/UTs, AIIMS & INIs/ hospitals of Central Ministries drafted for COVID-19 related responsibilities. The insurance provided under this scheme is over and above any other insurance cover being availed of by the beneficiary. There is no age limit for this scheme and individual enrolment is not required. The entire amount of premium for this scheme is being borne by the Ministry of Health and Family Welfare, Government of India. The benefit/claim under this policy is in addition to the amount payable under any other policies. Ministry of Health and Family welfare has collaborated with the New India Assurance (NIA) Company Limited for providing the insurance amount based on the guidelines prepared for the scheme. Till date, under the scheme, a total of 61 claims are processed and paid. 156 claims are under examination by New India Assurance (NIA) Company Limited, and in 67 cases claims forms are yet to be submitted by the States. PMGKP Insurance Scheme States/UTs: Summary of the claims as on 15/09/2020 S. No. State/UT Claims Received by NIA Claim processed By NIA Claim forms under examination At NIA Claims not eligible** Claim forms awaited From states 1 Andaman & Nicobar 0

31. Increase in Mental Health issues during the Pandemic
Tuesday September 15 2020 : Realizing the impact that COVID-19 may have on the mental health of the people, including children, the Government has taken a number of initiatives to provide psychosocial support during COVID-19. These initiatives include: Setting up of a 24/7 helpline to provide psychosocial support, by mental health professionals, to the entire affected population, divided into different target groups viz children, adult, elderly, women and healthcare workers. Issuance of guidelines/ advisories on management of mental health issues, catering to different segments of the society. Advocacy through various media platforms in the form of creative and audio-visual materials on managing stress and anxiety, and promoting an environment of support and care for all. Issuance of detailed guidelines by the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru- "Mental Health in the times of COVID-19 Pandemic - Guidance for General Medical and Specialized Mental Health Care Settings". All the guidelines, advisories and advocacy material can be accessed on Ministry of Health and Family Welfare website under “Behavioural Health – Psychosocial helpline” (https://www.mohfw.gov.in/) Online capacity building of health workers by NIMHANS in providing psychosocial support and training through (iGOT)-Diksha platform. Lack of sufficient mental health professionals is one of the challenges faced in the mental healthcare service delivery. The year-wise, State-wise details of mental health practitioners however is not maintained centrally. With a view to augment the availability of qualified manpower in field of mental health, the Government, under NMHP, is implementing manpower development schemes for establishment of Centres of Excellence and strengthening/ establishment of Post Graduate (PG) Departments in mental health specialties. Till date, support has been provided for establishment of 25 Centres of Excellence and strengthening/ establishment of 47 Post Graduate (PG) Departments in mental health specialties in the country. The Government is also augmenting the availability of manpower to deliver mental healthcare services in the underserved areas of the country by providing online training courses to various categories of general healthcare medical and para medical professionals through the Digital Academies established at the three Central Mental Health Institutes namely National Institute of Mental Health and Neuro Sciences, Bengaluru, Lokopriya Gopinath Bordoloi Regional Institute of Mental Health, Tezpur, Assam, and Central Institute of Psychiatry, Ranchi. The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here today. Sources https

32. COVID-19 Fatalities amongst Healthcare Workers
Tuesday September 15 2020 : Health is a State subject. Such data is not maintained at Central level by Ministry of Health and Family Welfare. However, database of those seeking relief under the “Pradhan Mantri Garib Kalyan Insurance Package” is maintained at national level. Ministry of Health and Family Welfare provided guideline on Infection Prevention and Control practices to the State Governments. Training was conducted for all the States in the month of March 2020. A training plan was also conveyed to States to complete training up to district level by 20th March 2020. Training on Infection Prevention and Control was also made available for all category of healthcare workers on the iGoT platform. States were asked to constitute Infection Prevention and Control committees. Hospitals were also to identify a nodal officer who will monitor the healthcare workers and review their exposure status. High risk exposures are placed under quarantine for 7 days. Based on their exposure/clinical profile such doctors, nursing officers and other health workers, a decision shall be taken by the Nodal Officer/Head of the Department (or his appointed Sub-committee) for further period of one week. An advisory for managing health care workers working in COVID and Non-COVID areas of the hospital was issued by Ministry of Health and Family Welfare on 18th June, 2020. Guidelines on rational use of PPEs for hospital and community settings (including front line workers) were issued on 24.03.2020. These guidelines followed a risk based approach and recommended type of PPE that needs to be used in high and low risk areas. The healthcare workers were provided with hydroxychloroquine for prophylaxis and prevention of infection. N-95 masks and triple / double ply masks were brought under price control. Export of PPEs, N 95 masks, triple/ double ply medical masks, goggles and visors were banned till such time we were self-reliant. The package of Rs 15000 crores (USD 2 Billion) under “India COVID-19 Emergency Response and Health System Preparedness Package” was been approved by the Cabinet on 22nd April, 2020. The funds and commodities are allocated to the states under various components including Emergency COVID-19 response. The States were supported with 9.81 Crore tablets of Hydroxychloroquine and 28,476 ventilators supplied to States/UTs. Initial part of the Pandemic, there were concerns on non-availability of protective gears. However, with Government of India stepping in to enhance capacity and allocating PPE to States as per need, this concern was addressed. States/UTs were provided with 3.05 crore N-95 masks and 1.2 Crore PPE kits. State-wise details of number of health care workers for whom the relief has been sought under “Pradhan Mantri Garib Kalyan Package” is given below: No. of Health workers died due to COVID-19 as per PMGKP: Insurance Scheme

33. Human Microbiome-based Products Market is projected to be worth USD 4 Billion - Roots Analysis
Wednesday April 21 2021 : Human Microbiome-based Products Market is projected to be worth USD 4 Billion - Roots AnalysisOver the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings. The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories soon. To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html Key Market Insights 260 therapy candidates are currently in different phases of development Nearly 25% of pipeline drugs are in the clinical phase of development, while the rest are in the preclinical / discovery stage. Interestingly, most of these drugs target digestive and gastrointestinal disorders (20%); this is followed by product candidates intended for treatment of oncological disorders (17%) and infectious diseases (13%). Over 30 microbiome diagnostic tests are currently available / under development Around 30% of the abovementioned tests have been commercialized, while the rest are under development. Of the total tests, notable examples of companies that launched a microbiome-based diagnostic solution include (in alphabetical order) ARTPred, Genetic Analysis, Goodgut, Invivo Healthcare, IS-diagnostics, Luxia Scientific and Varinos. FMTs are the only commercially available microbiome therapy This therapeutic product is presently indicated for the treatment of recurrent Clostridium difficile

34. COVID Vaccination Administration Training Programme for health care workers belonging to target group of NBCFDC
Tuesday February 2 2021 : The National Backward Classes Finance and Development Corporation (NBCFDC) has signed an MOU with M/s. Apollo Medskills Pvt Ltd. for providing COVID Vaccination Administration training programme (as per guidelines of Ministry of Health and Family Welfare) to Nurses, Medical & Nursing students and Pharmacist belonging to the target group of National Backward Classes Finance and Development (NBCFDC) on a co-funding basis. The programme has been sanctioned with the aim of Up-Skilling the competency level of the health care-workers as well contributing to the national programme of Vaccination under progress. The Corporation has sanctioned training programme for 1000 trainees in the state of Bihar, Delhi, Telangana, Tamil Nadu and Uttar Pradesh, which are expected to be commenced in due course. This information was given by Minister of State for Social Justice and Empowerment Shri Krishan Pal Gurjarin a written reply in Lok Sabha today. https://pib.gov.in/PressReleasePage.aspx?PRID=1694468

35. biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030-
Friday April 23 2021 : biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030- With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator companies alone London Roots Analysis has announced the addition of “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030” report to its list of offerings. Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs. To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html Key Market Insights Over 25 players claim to provide microbiome-based live biotherapeutics contract manufacturing More than 80% of the companies engaged in this domain are mid-sized and large firms; examples of firms established in 2019 include Arranta Bio and BacThera (a Lonza and Chr. Hansen joint venture). Further, nearly 50% of the CMOs have established the necessary expertise for handling both anaerobic and aerobic strains. 35+ manufacturing facilities focused on live biotherapeutics have been established worldwide Majority (~55%) of the manufacturing facilities are located in Europe, followed by North America. Prominent manufacturing hubs in the Europe include (in decreasing order of number of manufacturing facilities) the UK, France, the Netherlands, Italy, Germany, Switzerland, and Sweden. Approximately 88% of the total installed capacity is dedicated to commercial scale manufacturing Whereas, rest (~10%) of the capacity is being used for preclinical / clinical scale manufacturing of microbiome products. In addition, over 60% of the total current global, installed manufacturing capacity is installed in Europe. Over 170 registered clinical trials involved the use of microbiome-bas

36. The “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: , 2020-2030” -
Friday April 23 2021 : The “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: , 2020-2030” - To order this detailed 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html Key Inclusions A detailed review of the overall landscape of companies offering contract services for manufacturing of microbiome therapeutics, including information on year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of headquarters, type of service(s) offered (strain isolation, media / culture development, fermentation, lyophilization, fill / finish, cell banking, and analytical services), type of product manufactured (active pharmaceutical ingredients (API) and finished drug formulations (FDF)), type of drug molecule (small molecules and biologics / live biotherapeutics (LBPs)), type of fermentation (aerobic and anaerobic), type of formulation (solids (tablets / capsules / powders / granules), oral liquids (syrups and solutions), injectables and others), type of primary packaging used (ampoules / vials, blister packing, glass / plastic bottles, pouches / sachets, and others), number and location of manufacturing facilities (country-wise), facility size (if available), as well as their certifications, and company's contact details. A list of companies with in-house manufacturing facilities for microbiome therapeutics along with information on year of establishment, company size, scale of operations (preclinical, clinical and commercial), location of headquarters, and location of manufacturing facilities (country-wise). Elaborate profiles of key industry players (large and mid-sized companies, established before 2000) based in North America, Europe and Asia-Pacific that offer contract manufacturing services for microbiome therapeutics at both clinical and commercial scales. Each profile features a brief overview of the company, microbiome-related service portfolio, information on microbiome manufacturing facilities (if available), and recent developments and an informed future outlook. An assessment of microbiome contract manufacturing capability in different regions, based on a number of relevant parameters, such as number of CMOs, number of completed / active / planned clinical trials, number of patients enrolled, number of manufacturing facilities, number of companies offering API / FDF manufacturing, number of companies having capabilities for preclinical / clinical / commercial manufacturing, number of companies dedicated to aerobic / anaerobic fermentation, installed manufacturing capacity, and number of in-house players. A list of

37. Live Biotherapeutic Products and Microbiome Contract Manufacturing Market by Roots Analysis
Monday August 23 2021 : Live Biotherapeutic Products and Microbiome Contract Manufacturing Market by Roots AnalysisWith over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator companies alone London Roots Analysis has announced the addition of “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030” report to its list of offerings. Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs. To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html Key Market Insights Over 25 players claim to provide microbiome-based live biotherapeutics contract manufacturing More than 80% of the companies engaged in this domain are mid-sized and large firms; examples of firms established in 2019 include Arranta Bio and BacThera (a Lonza and Chr. Hansen joint venture). Further, nearly 50% of the CMOs have established the necessary expertise for handling both anaerobic and aerobic strains. 35+ manufacturing facilities focused on live biotherapeutics have been established worldwide Majority (~55%) of the manufacturing facilities are located in Europe, followed by North America. Prominent manufacturing hubs in the Europe include (in decreasing order of number of manufacturing facilities) the UK, France, the Netherlands, Italy, Germany, Switzerland, and Sweden. Approximately 88% of the total installed capacity is dedicated to commercial scale manufacturing Whereas, rest (~10%) of the capacity is being used for preclinical / clinical scale manufacturing of microbiome products. In addition, over 60% of the total current global, installed manufacturing capacity is installed in Europe. Over 170 registered clinical trials involved the use of microbiome-based live biotherapeutics

38. Leading Medtech player Healthium ramps up operations to ensure critical deliveries to healthcare providers are met within 24 to 48 hours
Wednesday May 26 2021 : Leading Medtech player Healthium ramps up operations to ensure critical deliveries to healthcare providers are met within 24 to 48 hours · Company has kept manufacturing facilities open during Lockdown and stepped up production of essential medical devices · Supply chain has been expanded 40% to support quicker deliveries and access healthcare facilities in remote parts of the country · Ramped up stock of critical product codes required for child birth and emergency surgeries Bengaluru, India:Healthium Medtech, a global leader in medical devices, today announced that it has strengthened its operations to fast track delivery of essentialmedical devices as the country fights the ongoing battle against COVID-19. In order to address the country’s need for essential medical consumables, Healthium Medtech has scaled its production, extended its supply chain and fast-tracked the deliveries of essential medical devices and consumables to support healthcare frontline workers. To ensure adequate supply of medical devices for healthcare practitioners, the company is running its plants during lockdown with due permissions and pre-cautionary measures. The company has also expanded supply chain by 40% to fast track critical deliveries. Considering the surge in demand for gloves at hospitals across the country, the company has utilized multiple production lines, and also stepped up production of1st of its kind Anti-microbial gloves TRUSHIELD, that protects both surgeons and patients against microbes. A significant production of gloves have been earmarked for government hospitals. The company has also provisioned for up to 2 months of stock of critical products codes for emergency surgeries like cardio-vascular surgeries and OB-GYN led surgeries, which continue despite the pandemic. Commenting on the contribution, Mr. Anish Bafna, MD & CEO, Healthium Group said, “The Healthcare industry has been at the forefront in the fight against COVID. While we continue to supportthem withmedical devices and essential consumables by keeping our manufacturing facilities running during Lockdown with due safety precautions, we are also constantly evaluating how we can optimise on our operations and have reduced the time to market. We are acutely aware of the burden on the system that is not only catering to COVID emergencies but other emergency surgeries that need to be prioritised amidst the ongoing stretch and have provisioned essential products to support these.We are committed to work in solidarity with the industrythrough this situation.” On its efforts towards safeguarding employee health and well-being the company has been organising vaccination drives, mental counselling sessions and several safety measures at the manufacturing facilities including availability of oxygen concentrators in case of need. For the financia

39. SIGNS YOU HAVE AN UNHEALTHY GUT AND HOW TO FIX IT
Monday November 18 2019 : The following are the tell tale signs that you might be taking an unhealthy gut. 1.An upset stomach. Microbial colonies in the gut are responsible for digestion of food. Diarrhea, constipation, bloating, nausea, heartburn, reflux, inflammatory bowel disease, colitis can be a few results of an imbalance in the gut flora. 2.Constant food cravings. Craving food, especially sweets and sugars can mean you have an imbalance of gut bacteria. 3. If you are suddenly loosing or gaining weight. Certain types of gut bacteria can cause either an increase or decrease in weight an imbalance in the gut flora can cause weight loss due to impaired vitamin, mineral and fat absorption or cause weight gain due to more caloric absorption from food than the others. 4.You are anxious or depressed and sleeping irregularly. As discussed, serotonin is majorly produced in gut. When less serotonin is produced it can affect your mood, social behavior, sleep, appetite, memory and even libido. It can also lead to insomnia and chronic fatigue. 5.Your skin is acting up. Skin rashes, or inflammation can be a sign of poor gut health an imbalance in gut bacteria can cause inflamed and itchy red blotches on the skin. Also following are the methods to improve your gut health 1.Lower your stress. Stress impacts the gut in a very bad way. To improve your gut health, one needs to lower their stress levels. 2.Get enough sleep. Not getting enough quantity of quality sleep can have. Have a negative impact on gut health. Try to have an 7 – 8 hours of uninterrupted sleep per night to lead to a healthier gut. 3.Eat slowly. Chewing food thoroughly and slowly can help in enhanced digestion and absorption of nutrients in turn reducing digestive discomfort and gut flora imbalance. 4.Stay hydrated. Drinking Plenty of water keeps the mucosal lining healthy promoting the balance of good bacteria in gut. 5.Go pro on probiotics or prebioties. Probiotic i.e. live good bacteria and prebiotic i.e. food for good bacteria can have a great impact on human gut health. Including a prebiotic or probiotic supplement to your diet is a great way to improve your gut health. So include these methods in your daily life to stay gut healthy and happy. An upset stomach.

40. The opportunity for AR / VR based digital marketing service providers in healthcare sector is projected to be worth USD 3 billion by 2030 at significant CAGR of 26% claims, Roots Analysis
Monday July 19 2021 : The opportunity for AR / VR based digital marketing service providers in healthcare sector is projected to be worth USD 3 billion by 2030 at significant CAGR of 26% claims, Roots AnalysisReport Keywords- Healthcare, Digital Marketing, Healthcare Digital Marketing, Pharma, Biotech Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings. Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers in the foreseen future. Owing to the rising interest of big pharma players in this domain, we expect an escalated industry-wide adoption of such technologies. To order this 180+ page report, which features 45+ figures and 70+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html Key Market Insights More than 125 companies claim to offer different AR / VR based digital marketing services to the healthcare and pharma industry. The majority of players engaged in providing AR / VR based digi

41. Cabinet approves Production Linked Incentive Scheme for Pharmaceuticals
Wednesday February 24 2021 : The Union Cabinet, chaired by the Prime Minister, Shri Narendra Modi has approved Production Linked Incentive (PLI) Scheme for Pharmaceuticals over a period of Financial Year 2020-21 to 2028-29. The Scheme will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for consumers. The scheme is expected to promote the production of high value products in the country and increase the value addition in exports. Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28. The scheme is expected to generate employment for both skilled and un-skilled personnel, estimated at 20,000 direct and 80,000 indirect jobs as a result of growth in the sector. It is expected to promote innovation for development of complex and high-tech products including products of emerging therapies and in-vitro Diagnostic Devices as also self-reliance in important drugs. It is also expected to improve accessibility and affordability of medical products including orphan drugs to the Indian population. The Scheme is also expected to bring in investment of Rs.15,000 crore in the pharmaceutical sector. The scheme will be part of the umbrella scheme for the Development of Pharmaceutical Industry. The objective of the scheme is to enhance India's manufacturing capabilities by increasing investment and production in the sector and contributing to product diversification to high value goods in the pharmaceutical sector. One of the further objectives of the scheme is to create global champions out of India who have the potential to grow in size and scale using cutting edge technology and thereby penetrate the global value chains. The salient features of the Scheme are as follows:- Target Groups:

42. AYURVEDIC DIABETES PRODUCT IN PATNA
Sunday September 8 2019 : AYURVEDIC DIABETES PRODUCT IN PATNA Diabetes Patra is natural remedies for diabetes . A Vijak tree’s bark is used to make this wooden glass, which is an effective herb in Ayurveda to control diabetes from ancient time. According to Ayurveda, Vijak purifies blood, remove all toxins from body, reduce blood sugar and restore each and every cell of the body which make it most effective herbs of diabetes.Diabetes is a metabolic disease in which a person has high blood sugar because of inadequate level of insulin in the body i.e. pancreas does not produce enough insulin. Patients with high blood glucose develop an unquenchable thirst and hunger and become frustrated because of the problem of polyuria (frequent urination) . Mobile : 9431021838 , 9955790682 landline : 0612-2354372 Fax : 9386387400 Address : At-Bhawani Timber Works, Main Road Kankarbagh,Patna Location: Patna

43. Pre-disease management, Utilization of data, Eldercare offer opportunities for healthcare start-ups in the country
Tuesday July 6 2021 : Pre-disease management, Utilization of data, Eldercare offer opportunities for healthcare start-ups in the country Experts share insights at IIHMR University during a webinar on- How to become a 21st-century health start-up Jaipur, 6thJuly, 2021:The pandemic has burdened the whole healthcare ecosystem which has pushed us to build and develop innovative solutions to overcome this crisis. IIHMR University Jaipur a leader in higher education organised a talk where experts from various organisations in the healthcare domain shared their insights on – How to become a 21st-century health start-up. Raghuram Janapareddy, Partner & Managing Director India at Tenthpin Management Consultants, Neha Rastogi, Founder and COO at Agatsa TIE-BIRAC Winner Awardee, Udayan Lahiry, Co-Founder & MD at Medica Hospitals Pvt Ltd., Kolkata, Vaibhav Tewari, Co-Founder & COO at Portea Medical, Bhavesh Kothari, Co-Founder & Director at Billennium Divas, Dr. PR Sodani, President at IIHMR University Jaipur shared their views. Dr. Pallavi Chaudhary Agarwalla, Head Incubation-CIIE at IIHMR University Jaipur and Dr. Sheenu Jain, Associate Professor, Chair – CIIE at IIHMR University Jaipur moderated the talk. The webinar addressed the most pressing problems in the healthcare domain during the COVID-19 pandemic. Mr. Raghuram Janapareddy, Partner & Managing Director India at Tenthpin Management Consultants spoke on the country’s landscape of innovations in the health sector and the role of health tech start-ups. He said the healthcare has gone into a multi-dimensional approach where he elaborated and said, “The country’s landscape is humungous. When one looks at the recent pandemic, there have been a lot of repurposed innovations coming into the market and the focus has shifted positively for the core innovation of treatment to delivery. Putting the solutions spectrum in healthcare delivery on 5 dimensions a. Diagnostics which are the usual body indicators, diagnostics related to X-Rays, Blood Culture. B. Innovations that have helped the doctors to make informed decisions, c. Delivery ranges from IPD, OPD, automation or solutions at the door step of the PHC, delivery concerning home healthcare, delivery concerning clinical trials and remote patient management. The fourth point i.e on data, on how do we collect data concerning patient life-cycle, data on rare diseases, data that would be helpful in the therapeutic area, and the fifth point e. role of healthcare start-ups and innovations and the tech in healthcare inclusion of AI in healthcare. The speed of innovations of start-ups after the pandemic. The rise of innovations through AI in the healthcare system has been a changeover in the healthcare sector especially in the area of surgery.” Mr. Vaibhav Tewari, Co-Founder & COO at Portea Medical, focussed on the area of the advantages of being a 21st-century health start-up in India and the opportunities for these start-ups. He also

44. Human Microbiome-based Products Market is growing at an annualized rate of over 40%- Roots Analysis
Wednesday April 21 2021 : Human Microbiome-based Products Market is growing at an annualized rate of over 40%- Roots AnalysisOver the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes: A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s). Elaborate profiles of key players (established after 2005) that are engaged in the development of microbiome therapeutics. A detailed review of the current market landscape of microbiome diagnostic tests, brief profiles of popular diagnostic developers and indicative list of screening and profiling test kits. A detailed assessment of the current market landscape of FMT therapies, a geographical clinical trial analysis and information on various stool banks. A detailed business portfolio analysis based on an attractiveness and competitiveness (AC) framework. An analysis of the varied microbiome-focused initiatives of big pharma players. An analysis of the start-ups / small-sized players engaged in the development of microbiome therapeutics and diagnostics. An assessment of the most commonly targeted therapeutic indications and details of microbiome-based drugs. An analysis of the investments made at various stages of development in start-ups / small-sized companies. An indicative list of contract manufacturers, in-house manufacturers and CROs that currently claim to have the necessary capabilities. An assessment of the emerging role of big data highlighting efforts focused on the development and implementation of various algorithms / tools to analyze data generated from in the microbiome research. An informative case study on the various other applications of microbiome products, such as agriculture, animal health, plant health, food products A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below) segments:

45. eSanjeevani OPD of Health Ministry completes 3 lakh tele-consultations within six months of launch
Thursday September 24 2020 : eSanjeevani OPD platform of Ministry of Health and Family Welfare has completed 3 lakh tele-consultations. This landmark milestone has been achieved within a short period of six months since its launch. eSanjeevani OPD services have enabled patient-to-doctor telemedicine in midst of the COVID-19 pandemic. This has helped in containing the spread of COVID by ensuring physical distancing and has simultaneously enabled provisions for non-COVID essential healthcare. The number of high tele-consultations is a testimony of its popularity among the citizens. With 1,29,801 digital interactions, Tamil Nadu has held the largest number of tele-consultations so far. Tamil Nadu had been a pioneer in the field registering 32,035 OPD consultations by 9th August and 56,346 consultations by the 19th of the same month. The State had registered nearly one lakh consultations (97,204) by 8th September. The platform had provided essential healthcare to the State, one of the worst affected by COVID-19, at a critical time when conventional medicine was perceived to be risky owing to the nature of the infectious disease. Tami Nadu is followed by Uttar Pradesh (96,151 consultations), Kerala (32,921 consultations) and Uttarakhand (10,391 consultations). These four States account for 2,69,264 tele-consultations (89.75% of total consultations). With on boarding of Gujarat and UT of Jammu and Kashmir on eSanjeevaniOPD and Chhattisgarh on eSanjeevani (AB-HWC) the total no. of States and UTs using eSanjeevani has gone up to 26. Around 4,600 doctors have been trained on eSanjeevaniOPD and on an average over 6000 consultations / day are recorded in eSanjeevani’s national network. The aspect that makes eSanjeevani telemedicine platform special is that the Operations and Management of the platform has been organised in a very methodological manner. A close and an efficient connect is maintained between the States and the implementing agency (C-DAC Mohali). This enables quick feedback from the users which helps the implementing team to make quick optimisations. Accordingly, eSanjeevani is not only consistently increasing with respect to its efficiency / productivity but it is also getting enriched with newer functionalities and features as required by the users in the States. eSanjeevani platform has enabled two types of telemedicine services viz. Doctor-to-Doctor (eSanjeevani) and Patient-to-Doctor (eSanjeevani OPD) Tele-consultations. The former is being implemented through Ayushman Bharat Health and Wellness Centre (AB-HWC). It aims to implement tele-consultation in all 1.5 lakh HWCs in conjunction with identified Medical College hospitals in a ‘Hub and Spoke’ model. States have identified and set up dedicated ‘Hubs’ in Medical Colleges and District hospitals to provide tele-consultation services to ‘Spokes’, i.e SHCs, PHCs and HWCs. Health Ministry rolled out the second tele-consultation service ‘eSanj

46. The contract manufacturing market for live biotherapeutics and microbiome products is growing at a CAGR of 46%-
Friday April 23 2021 : The contract manufacturing market for live biotherapeutics and microbiome products is growing at a CAGR of 46%- Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs. Roots Analysis is pleased to announce the publication of its recent study, titled, “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030.” The report features an extensive study of the current landscape and future opportunities related to contract services for microbiome therapeutics. The study features an in-depth analysis, highlighting the capabilities of a diverse set of contract service providers, including CMOs and CDMOs. Amongst other elements, the report includes: A detailed review of the overall landscape of companies offering contract services for manufacturing of microbiome therapeutics. A list of companies with in-house manufacturing facilities for microbiome therapeutics. Elaborate profiles of key industry players (large and mid-sized companies, established before 2000) based in North America, Europe and Asia-Pacific. An assessment of microbiome contract manufacturing capability in different regions. A list of nearly 50 microbiome-focused drug developers that are anticipated to partner with contract manufacturers. A detailed clinical trial analysis of more than 150 completed, ongoing and planned studies of various microbiome therapeutics sponsored by both industry and non-industry players. An estimate of the overall, installed capacity for manufacturing of microbiome therapeutics, taking into consideration the capabilities of various stakeholders. An informed estimate of the annual clinical demand for microbiome therapeutics, taking into account the target patient population in ongoing and planned clinical trials of microbiome therapeutics, sponsored by both industry and non-industry players. A qualitative analysis, highlighting the various factors that need to be taken into consideration by microbiome therapeutics developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO. A review of the varied microbiome-focused initiatives of big pharma players. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segm

47. Venus Remedies enters consumer healthcare business with R3SET launch
Thursday July 15 2021 : Venus Remedies enters consumer healthcare business with R3SET launch ● To introduce disruptive products overthe next fiveyears, covering key segments like pain management, gastro-enterology, hygiene, stress management, vitamins, and supplements ● Offers holistic pain management solution called R3SET, which ensures maximum efficacy by combining the goodness of proven essential oils with nanotechnology Mumbai, July 15, 2021: Foraying into the Rs 30,000-crore Indian consumer healthcare market with its innovative and highly efficacious natural solutions covering an array of segments, Venus Remedies Ltd, a leading research-driven pharmaceutical company, launched its full-fledged Consumer Healthcare Division today. Employing latest state-of-the-art technologies backed by cutting-edge research spearheaded by the Venus Medicine Research Centre (VMRC), the R&D wing of Venus Remedies, the company’s Consumer Healthcare Division will come up with a wide range of products covering the crucial pain management, gastroenterology, hygiene, stress management and vitamins and supplements segments. Stating that the newly launched business division would introduce disruptive products in these segments in India over the next five years, Mr Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd, and CEO, VMRC, said, “We have charted a roadmap for addressing the needs of modern-day Indian consumers who, empowered by the digital revolution brought about by technology over the past decade, make informed choices by digging deeper into science and opt for remedies that work best for them. Never before has there been a time when consumers were both aware of their health needs and had the tools to assess the available solutions. We have entered this OTC space at an ideal time to cater to their specific requirements.” To begin with, the company’s Consumer Healthcare Division has introduced its holistic pain management solution called R3SET wherein the three “Rs” denote Relief, Revive and Restore. Focused on everyday healthcare solutions, the product line under this segment will help people deal with lifestyle-associated pains more effectively through a 360-degree self-care approach that blends latest technologies with time-tested natural remedies. The R3SET Life formula is a natural

48. Ayush Minister lays Foundation stone of Post Harvest Management Centre and E-Launches 21 AYUSH Health & Wellness Centres in J&K
Sunday September 27 2020 : Shri Shripad Naik Union Minister of State (Independent Charge) for AYUSH and Dr. Jitendra Singh, Union Minister of State for the Prime Minister Office and Ministry of Development of North Eastern Region, have laid Foundation Stone for Post Harvest Management Centre for Medicinal Plants at Bhaderwah and inaugurated 21 AYUSH Health & Wellness Centres in Jammu & Kashmir on 25th Sept 2020 through video conferencing. The purpose of establishing Post Harvest Management Centre for Medicinal Plants is to develop facilities for drying, sorting, processing, certification, packaging, and safe storage of herbal raw materials produced and collected by local people so that its quality is enhanced to fetch better price and augment the income of farmers associated. During the event, 21 AYUSH Health and Wellness Centres were also inaugurated under Ayushman Bharat in Jammu & Kashmir. A holistic wellness model would be created through these centres to reduce the disease burden and out of the pocket expenditure. The main focus of AYUSH interventions would be to empower masses for “self-care” on the prevention of diseases through a healthy lifestyle, food, Yoga, and medicinal plants. Shri, Shripad Naik in his address stated that the “Post Harvest Management Centre” of medicinal plants in the Bhaderwah region of Jammu & Kashmir was a long pending demand of people of this area and highlighted the big potential of the region in the cultivation of many Himalayan medicinal plant species. Minister appreciated the effort of UT Government officials in implementing a centrally sponsored program and stated that Govt. of India is according top priority to J&K for accelerating the pace of development. Dr. Jitendra Singh, during his address highlighted that this Post Harvest Centre will create Employment Avenue among the youth in addition to other facilities provided for the growers and collectors of medicinal plants. Further, he empathized that the AYUSH Health and Wellness Programme will not only provide services to the needy people but also promote AYUSH at the international level. Sources https://pib.gov.in/PressReleseDetail.aspx?PRID=1659272

49. Ophthalmic products are currently available for various therapeutic, diagnostic & monitoring and drug delivery applications
Wednesday April 28 2021 : Ophthalmic products are currently available for various therapeutic, diagnostic & monitoring and drug delivery applicationsAdvancements in the domain of ophthalmology continue to expand the range of potential application areas for contact lenses. Presently, over 55 novel ophthalmic products have been developed or are being developed for the treatment of various ophthalmological disorders, diagnosis / monitoring of diseases and for restoring vision in the blind. The ongoing efforts to innovate in this domain are evident from the fact that more than 7,500 patents have been granted / filed since 2013. To order this 230+ page report, which features 115+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/next-generation-contact-lenses-and-visual-prostheses-market-2019-2030/244.html The USD 3.7 billion (by 2030) financial opportunity within the next generation immune checkpoint modulators market has been analyzed across the following segments: Type of Product Contact Lenses Visual Prostheses Type of Lenses Therapeutic Contact Lenses Drug-eluting Contact Lenses Diagnostics and Monitoring Contact Lenses Target Indication Age-related Macular Degeneration Aniridia Diabetes Glaucoma Retinitis Pigmentosa Key Geographical Region North America EU5 Asia-Pacific The “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030.” report features the following technologies, which we identified to be key players in this domain: EyePrint Prosthetics University of Washington Leo Lens Technology Baylor College of Medicine iBIONICS To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/next-generation-contact-lenses-and-visual-prostheses-market-2019-2030/244.html Contac

50. Healthium acquires CareNow,strengthens R&D capabilities and portfolio with differentiated and patented products
Wednesday September 1 2021 : Healthium acquires CareNow,strengthens R&D capabilities and portfolio with differentiated and patented products · Healthium’s third acquisition in 2021 · Adds patented wound management products and enhances R &D capabilities Mumbai, September 01, 2021:Healthium, a global player in medical devices, today announced the successful acquisition of CareNow Medical Private Limited, strengthening its product portfolio with patented and differentiated products in the advanced wound management and infection prevention segments. This is the third acquisition by Healthium in calendar year 2021. Earlier this year, Healthium had acquired the AbGel business in India and VitalCare in the United Kingdom to expandits surgical and post-surgical care portfolio. Healthium’s product portfolio coverssurgical consumables, urology and arthroscopy products. Its manufacturing facility at Bangalore is registered with US FDA. CareNow is primarily engaged in the designing, manufacturing, marketing and sale of products in the focus area of advanced wound management and infection prevention for patients and hospitals. With this acquisition, Healthium strengthens its portfolio of patented products through the addition of CareNow’s advanced wound dressing which has patents across US, Europe and India.Further, the acquisition adds to Healthium’s manufacturing and R&D capabilities. CareNow’s manufacturing facility in Coimbatore is US FDA registered and will count as the 8th manufacturing facility for Healthium. Speaking on the acquisitionAnish Bafna, CEO and MD, Healthium Medtech, said, “With the acquisition of a high-tech patent drivencompany like CareNow, we are proud to strengthen our advanced wound management and infection prevention segmentsby adding patented productsmade to globally accepted quality standards. We look forward to offeringwider choices to our customers and delivering better standards in patient care worldwide. ” Anand Venkatachalam, COO, CareNow Medicaladded “We are happy to find in Healthium, the right partner to enableour products including the patented and Innovative product range,to be accessed by a larger Indian audience and also reach the global market through their distribution network. We are excited that this partnership will result in the healthcare systems of 80 countries benefitting from our patented products. About Healthium Healthium is a global medtech company focused on products used in surgical and post-surgical care. Healthium is focused on developing and manufacturing quality products to meet the needs of patients and healthcare professionals w

Practice Set by Subject General Awarness English Reasoning Mathematics Computer Awarness

Popular Contents

PUBLIC HEALTH AND MENTAL WELLBEING DISCUSSION SERIES: ISSUES, CHALLENGES, AND SOLUTIONS AMID COVID 19

PUBLIC HEALTH AND MENTAL WELLBEING DISCUSSION SERIES: ISSUES, CHALLENGES, AND SOLUTIONS AMID COVID 19 445

Health Tuesday September 14 2021

Choosing the Right Nutritional Products for Kids in Post Covid Era

Choosing the Right Nutritional Products for Kids in Post Covid Era 179

Health Thursday September 2 2021

Fitness Tracker Market 2021 Size & Share | Market worth USD 91.98 billion with 15.2% CAGR by 2027

Fitness Tracker Market 2021 Size & Share | Market worth USD 91.98 billion with 15.2% CAGR by 2027 124

Health Thursday September 16 2021

Genomics has been a game-changer during Sars COV-2- Founder & CEO, Medix Global, UK shared insights in a discussion at IIHMR University

Genomics has been a game-changer during Sars COV-2- Founder & CEO, Medix Global, UK shared insights in a discussion at IIHMR University 85

Health Thursday July 1 2021

Webinar on “POSHAN Abhiyaan – Sahi Poshan Desh Roshan” organized today

Webinar on “POSHAN Abhiyaan – Sahi Poshan Desh Roshan” organized today 45

Health Friday September 10 2021

Poshan 2.0 Quiz

Poshan 2.0 Quiz 44

Health Thursday September 9 2021

Best IVF Centre in kanpur- Pravi IVF and Fertility centre

Best IVF Centre in kanpur- Pravi IVF and Fertility centre 38

Health Thursday July 15 2021

मधुमेह का अचूक और सफल उपचार क्या है

मधुमेह का अचूक और सफल उपचार क्या है 37

Health Sunday September 8 2019

AYU SAMVAD Campaign (My Health My Responsibility)

AYU SAMVAD Campaign (My Health My Responsibility) 36

Health Tuesday January 26 2021

CoWin (Covid-19) Vaccine Certificate PDF Download Procedure

CoWin (Covid-19) Vaccine Certificate PDF Download Procedure 34

Health Saturday May 15 2021

Subh Ravivar (Sunday)

Subh Ravivar (Sunday)
Sunday 19th of September 2021

जीवित्पुत्रिका या जितिया Jivitputrika (also called Jitiya) Pictures, Images, Photos

जीवित्पुत्रिका या जितिया Jivitputrika (also called Jitiya) Pictures, Images, Photos

Online Practice Set for BPSC Prelims Exam

Online Practice Set for BPSC Prelims Exam

📂 Submit your RSS Feed on our website

📂 Submit your RSS Feed on our website

Big Celebration Sale 2021

Big Celebration Sale 2021

HINDU GOD AND GODDESS IMAGES, GIF, ANIMATED GIF, WALLPAPER, STICKER FOR WHATSAPP & FACEBOOK

HINDU GOD AND GODDESS IMAGES, GIF, ANIMATED GIF, WALLPAPER, STICKER FOR WHATSAPP & FACEBOOK

Recent Jobs

Recruitment for the post of State Project Manager (Capacity Building), State Project Manager (Project Intervention) & State Project Manager (Land Reform and Development) in Bihar Mahadalit Vikas Mission

Recruitment for the post of State Project Manager (Capacity Building), State Project Manager (Project Intervention) & State Project Manager (Land Reform and Development) in Bihar Mahadalit Vikas Mission 1186

Bihar Friday September 3 2021

Recruitment of Field Engineer Electrical/Mechanical in SJVN Limited 2021

Recruitment of Field Engineer Electrical/Mechanical in SJVN Limited 2021 461

Sarkari Naukri Monday August 30 2021

Statistical Officer Vacancy Recruitment by RPSC 2021

Statistical Officer Vacancy Recruitment by RPSC 2021 415

Rajasthan Monday August 30 2021

Keep India Smiling Foundational Scholarship Programme

Keep India Smiling Foundational Scholarship Programme 304

Scholorship Wednesday September 8 2021

Engineer Recruitment in PSU by GATE 2022

Engineer Recruitment in PSU by GATE 2022 266

Engineering Tuesday September 7 2021

NSP Pre-Matric Scholarship for Students with Disabilities 2021-22

NSP Pre-Matric Scholarship for Students with Disabilities 2021-22 257

Scholorship Wednesday September 8 2021

Recruitment of Job Vacancy in National Horticultural Research And Development Foundation (NHRDF) 2021

Recruitment of Job Vacancy in National Horticultural Research And Development Foundation (NHRDF) 2021 256

Sarkari Naukri Wednesday September 8 2021

SVPUAT Meerut Non-Teaching Recruitment 2021

SVPUAT Meerut Non-Teaching Recruitment 2021 252

Uttar Pradesh Tuesday September 7 2021

NSP Pre Matric Scholarships Scheme for Minorities 2021-22

NSP Pre Matric Scholarships Scheme for Minorities 2021-22 251

Scholorship Wednesday September 8 2021

BHEL Kolkata Civil Engineer Recruitment 2021

BHEL Kolkata Civil Engineer Recruitment 2021 249

West Bengal Tuesday September 7 2021

List Your Business for Free - Join Us & bring more customers

Business Directory

Admission Consultant Beautician Training Institutes Books Stores CA & ICWA Training Institutes Coaching College Competitive Exams Education & Jobs Education Consultants Fashion Designing Training Institutes Film And Television Institute Hardware And Network Training Institutes Institution Journalism Training Institutes Medical Colleges Music Academies Online Classes Online Examination Centre Radio Jockey Training Institutes Recruitment Agencies and Job Consultancy Research Institutes Robotics Training Institutes School School For Mentally Challenged Software Training Institutes Spoken English Institutes Sports Academies Sports Clubs Stationary Stores Training Institutes Tuitions Typing Institutes Universities University UPSC & IAS Coaching Centres Yoga Instructor

K.R. Mangalam University

K.R. Mangalam University - Universities

Sohna Road, Gurugram, Haryana 122103 Sohna Rural, Haryana HARYANA Gurgaon Tuesday July 27 2021 119

dridhOn - Education & Jobs

Bengaluru KARNATAKA Bangalore Urban Friday September 10 2021 119

Sann Consulting

Sann Consulting - Recruitment Agencies and Job Consultancy

# 108, 3rd Floor, RT Nagar Bangalore 560032 KARNATAKA Bangalore Urban Thursday August 5 2021 119

CLAT PATH - Institution

CLAT PATH Building, Near Indraprastha, Opp Godrej Interio, West Boring canal Roa BIHAR Patna Monday February 22 2021 120

PRABHUNATH COLLEGE, PARSA

PRABHUNATH COLLEGE, PARSA - College

PN College, Parsa, Saran BIHAR Saran( Chapra ) Friday March 26 2021 120

DAV PUBLIC SCHOOL

DAV PUBLIC SCHOOL - School

INDUPURAM, Laxmichack, Parsa Bazar, Sampat Chak Road, Patna BIHAR Patna Thursday April 1 2021 120

DON BOSCO PRIMARY SCHOOL

DON BOSCO PRIMARY SCHOOL - School

Building # 66 - Patliputra Colony BIHAR Patna Thursday April 1 2021 120

Delhi Public School

Delhi Public School - School

Vill. Chandmari, P.S. Shahpur, Danapur Cantonment, Patna BIHAR Patna Thursday April 1 2021 120

Samyak IAS–IAS Coaching in Jaipur

Samyak IAS–IAS Coaching in Jaipur - Education Consultants

SP-21, Above Canara Bank, Near Riddhi Siddhi, Gopal Pura Bypass RAJASTHAN Jaipur Saturday May 1 2021 120

DON BOSCO ACADEMY

DON BOSCO ACADEMY - School

Vil- Konka P.O. McCluskiegunj Ranchi JHARKHAND Ranchi Thursday April 1 2021 120

List Your Business for Free | Login to manage your Business Page

Submit Guest Post Guest Post Submit Job Information Submit Contents
Category Contents Jobs Link Photo Video Business Directory
Our presence in social media Twitter Facebook Telegram Whatsapp Grroup vk.com Flipboard
Contact us Contact us
Explore more Web Archive Free Online Practice Set Our Blog Search Pincode Search Bank IFSC Code Best Deal Greetings Recent Jobs RSS Advertise with us Question follow.it Sitemap
Tag Tag Search

We would love to hear your thoughts, concerns or problems with anything so we can improve our website educratsweb.com ! Email us at educratsweb@gmail.com and submit your valuable feedback.
Save this page as PDF

© 2021 educratsweb.com. | Designed & Developed by educratsweb.com Email us at educratsweb@gmail.com